Semliki Forest viiruse replikatsiooni ja patogeensuse uurimine by Tamberg, Nele
 DISSERTATIONES BIOLOGICAE UNIVERSITATIS TARTUENSIS 
224 
 
 DISSERTATIONES BIOLOGICAE UNIVERSITATIS TARTUENSIS 
224 
 
 
 
 
 
 
 
 
NELE TAMBERG 
 
 
Studies on Semliki Forest virus 
replication and pathogenesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Institute of Molecular and Cell Biology, Faculty of Science and Technology, 
University of Tartu, Estonia. 
 
Dissertation was accepted for the commencement of the degree of Doctor of 
Philosophy in virology on July 3, 2012 by the Scientific Council of the Institute 
of Molecular and Cell Biology, University of Tartu, Estonia. 
 
Supervisor: Andres Merits, PhD, Professor of Applied Virology, 
Institute of Technology, University of Tartu, Estonia 
 
Opponent:  Gorben Peter Pijlman, PhD, Assistant Professor, Laboratory 
of Virology, Wageningen University, the Netherlands 
 
Commencement:  Room No 105, Riia 23C, Tartu, on October 19, 2012, at 10.00. 
 
Publication of this thesis is granted by the Institute of Molecular and Cell 
Biology, University of Tartu and by the Graduate School of Biomedicine and 
Biotechnology created under auspices of European Social Fund. 
 
 
  
 
ISSN 1024–6479 
ISBN 978–9949–32–095–0 (trükis)  
ISBN 978–9949–32–096–7 (PDF) 
 
 
Autoriõigus: Nele Tamberg, 2012 
 
Tartu Ülikooli Kirjastus 
www.tyk.ee  
Tellimus nr 404 
 5
CONTENTS 
 
LIST OF ORIGINAL PUBLICATIONS  ......................................................  7 
LIST OF ABBREVATIONS  .........................................................................  8 
1.  INTRODUCTION  ....................................................................................  9 
2.  REVIEW OF LITERATURE  ...................................................................  10 
2.1. Alphaviruses  ......................................................................................  10 
2.2. Virion and genome organisation  .......................................................  11 
2.3. Infection cycle  ...................................................................................  12 
2.3.1. Virus entry  ..............................................................................  12 
2.3.2. Genome replication .................................................................  13 
2.3.3. Virion assembly and budding  .................................................  16 
2.4. Non-structural proteins  ......................................................................  17 
2.5. Virus-host interactions  ......................................................................  20 
2.5.1. Shutdown of host cell transcription and translation  ...............  20 
2.6. Infection of the nervous system  ........................................................   22 
2.6.1. Immune response in the mouse CNS  ......................................  23 
2.7. Alphavirus-based vectors  ..................................................................  24 
3.  RESULTS AND DISCUSSION  ..............................................................  28 
Objectives of the present study  ................................................................  28 
3.1. Design and characterisation of novel marker viruses (I, II)  ..............  28 
3.1.1. Design of novel marker viruses  ..............................................   28 
3.1.2. Characterisation of novel marker viruses in cultured  
cells (I, II)  ...............................................................................  30 
3.1.3. Genetic stability of recombinant viruses in vitro and  
in vivo (II)  ...............................................................................  31 
3.1.4. NsP3 carboxy terminus contains a hypothetical degradation 
signal (I)  .................................................................................  32 
3.2. Course of infection of recombinant viruses in adult mice (II)  ..........  33 
3.2.1. Neurons and oligodendrocytes differ in their ability to permit 34 
replication of SFV (II)  ......................................................................  34 
3.3. Mature but not immature neurons rapidly downregulate virus 
protein synthesis (II, unpublished)  ...................................................  35 
3.4. Properties of SFV4 and SFV A7(74) infection in immature and 
mature neurons (unpublished)  ..........................................................  36 
3.5. Properties of nsP1 and its interference with virus infection (III)  ......  38 
4. SUMMARY  ..............................................................................................  41 
REFERENCES  ..............................................................................................  43 
SUMMARY IN ESTONIAN  ........................................................................  54 
 
 
 6
ACKNOWLEDGEMENTS  ..........................................................................  56 
PUBLICATIONS  ..........................................................................................  57 
CURRICULUM VITAE  ...............................................................................  95 
 7
LIST OF ORIGINAL PUBLICATIONS 
 
This thesis is based on following publications that are referred to in the text by 
their Roman numerals: 
 
I Tamberg N.*, Lulla V.*, Fragkoudis R., Lulla A., Fazakerley J. K. and 
Merits A. (2007). Insertion of EGFP into the replicase gene of Semliki 
Forest virus results in a novel, genetically stable marker virus. J Gen Virol 
88:1225–1230. 
* Authors contributed equally to this work 
 
II Fragkoudis R., Tamberg N., Siu R., Kiiver K., Kohl A., Merits A. and 
Fazakerley J. K. (2009). Neurons and oligodendrocytes in the mouse brain 
differ in their ability to replicate Semliki Forest virus. J Neurovirol 15:57–
70. 
 
III Kiiver K.*, Tagen I.*, Zusinaite E., Tamberg N., Fazakerley J. K., and 
Merits A. (2008). Properties of non-structural protein 1 of Semliki Forest 
virus and its interference with virus replication. J Gen Virol 89:1457–1466. 
* Authors contributed equally to this work 
 
Articles are reprinted with the permission of copyright owners. 
 
In addition, some unpublished data are presented. 
 
 
Author’s contribution: 
 
I I designed and performed all of the experiments together with V. Lulla or 
R. Fragkoudis, except the immunoprecipitation experiments to analyse 
polyprotein processing. I actively participated in the analysis of the data 
and the writing of the manuscript. 
II  I performed, together with F. Fragkoudis, the animal pathogenesis studies 
of recombinant viruses. I actively participated in the analysis of the data 
and the writing of the manuscript. 
III I constructed and produced the recombinant viruses and participated in the 
growth curve experiments. 
 
 8
LIST OF ABBREVATIONS 
 
aa  amino acid 
C  capsid protein 
cDNA  complementary DNA 
CHIKV  Chikungunya virus 
CPV  cytopathic vacuole 
CSE  conserved sequence element 
CNS  central nervous system 
ds  double-stranded 
EEEV  Eastern equine encephalitis virus 
EGFP  enhanced green fluorescent protein 
eIF  eukaryotic translation initiation factor 
ER  endoplasmic reticulum 
FMDV  Foot and mouth disease virus 
GFP  green fluorescent protein 
GMP  guanosine monophosphate 
i.c.  intracerebral 
icDNA  infectious cDNA 
IFN  interferon 
i.p.  intraperitoneal 
IRES  internal ribosomal entry site 
kb  kilobase 
m7GMP  7-methyl-GMP 
MOI  multiplicity of infection 
ns  nonstructural 
nsP  nonstructural protein 
NLS  nuclear localisation signal 
NTR  nontranslated region 
pfu  plaque forming unit 
PKR  dsRNA-activated protein kinase 
RdRP  RNA-dependent RNA polymerase 
Rluc  Renilla luciferase 
RRV  Ross River virus 
SFV  Semliki Forest virus 
SINV  Sindbis virus 
ts  temperature-sensitive   
VEEV   Venezuelan equine encephalitis virus 
VLP  virus-like particle 
WEEV  Western equine encephalitis virus 
 9
 1. INTRODUCTION 
 
Alphaviruses are small, enveloped, positive-strand RNA viruses that are spread 
worldwide. This genus includes many important human and animal pathogens 
that cause different diseases, including arthralgia and encephalitis. Semliki 
Forest virus (SFV) is one of the best-studied alphaviruses and serves as one of 
the prototypes. Studies of SFV have revealed many important aspects about 
alphavirus infection, including receptor-mediated endocytosis for virus entry, 
spatially and temporally regulated viral RNA replication, and mechanisms of 
membrane protein transport. In addition, SFV-infected rodents serve as one of 
the general model systems for studies of viral encephalitis.  
Although alphaviruses have been extensively studied since their discovery 
more than 80 years ago, many questions concerning virus life cycle, virus-host 
interactions, and especially pathogenesis still remain unanswered. Several 
aspects of these processes are difficult to study, especially in living organisms, 
where infection is a complex process and involves different tissues and cell 
types. Recombinant viruses expressing marker proteins that are easy to visualise 
or quantify have facilitated infection studies of different viruses in both cultured 
cells and in animals. Unfortunately, most of designed alphavirus-based vectors 
tend to suffer from genetic instability, hampering their use in experiments where 
viral spread is needed. 
The aim of the studies that form the basis of the current thesis was to 
develop suitable tools and then employ them to study different aspects of SFV 
infection and pathogenesis. This thesis describes the successful construction of 
a novel marker protein-expressing recombinant SFV with a highly stable 
genome. Pathogenesis studies in adult mice exploiting these tools revealed new 
insights into the infection process of SFV in the mouse central nervous system 
and have aided in the understanding of how the mouse brain responds to 
alphavirus infection. This thesis also describes new findings about the effects of 
non-structural protein 1 (nsP1) and its non-palmitoylated mutant on the host cell 
and SFV infection cycle, as studied by use of constructed recombinant viruses. 
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2. REVIEW OF LITERATURE 
 
2.1. Alphaviruses 
 
The family Togaviridae contains two genera, genus Alphavirus and genus 
Rubivirus. Rubella virus is the only member of the genus Rubivirus. The genus 
Alphavirus has more than 30 members including several important human and 
animal pathogens (Strauss and Strauss, 2008). Alphaviruses are distributed 
worldwide; their isolates have been reported on all continents except Antarctica. 
All members of the genus are closely related and even the most distantly related 
viruses have approximately 40% amino acid sequence identity (Strauss and 
Strauss, 2008).  
Alphaviruses have classically been described as either Old World or New 
World viruses, based on the geographic location they were originally isolated. 
Old World viruses, including Chikungunya (CHIKV), O’nyong-nyong, Ross 
River (RRV), Sindbis (SINV) and Semliki Forest virus (SFV), are found in 
Europe, Africa, Asia and Australia and can cause fever, rash, and arthralgia. 
New World viruses, such as Western, Eastern and Venezuelan equine en-
cephalitis viruses (WEEV, EEEV, VEEV, respectively), are found in North and 
South America and typically cause encephalitis (Strauss and Strauss, 1994). 
The genus Alphavirus includes several important human and animal patho-
gens. EEEV and WEEV regularly cause fatal encephalitis in North and South 
America, although the number of people infected is generally small (Strauss and 
Strauss, 1994). VEEV is estimated to infect tens of thousands of people in Latin 
America every year. Typical symptoms of infection include headache, fever, 
myalgia and arthralgia; in some cases, neurological disease and death can occur 
(Aguilar et al., 2011). A recent CHIKV epidemic in Indian Ocean territories 
resulted in millions of infected people experiencing severe rash and joint pain 
and a mortality rate of 0.1% (Schwartz and Albert, 2010). Chikungunya fever 
has been identified in nearly 40 countries (Schwartz and Albert, 2010). 
Most alphaviruses are spread by blood-sucking arthropods, and in nature, 
they alternate between replicating in insect vectors, mostly mosquitoes, and 
higher vertebrates. In insect vectors, alphavirus replication is asymptomatic, 
resulting in persistent lifelong infection with minimal effect on the biological 
functions of the host. In vertebrates, the duration of infection is usually short 
and ends with the death of the infected host or clearance of the virus by the 
immune system (Strauss and Strauss, 1994). Replication in cultured cells 
mirrors these properties of the alphavirus life cycle. In cells of vertebrate origin, 
the viruses cause highly productive, cytopathic infection, while in mosquito 
cells, the infection is apathogenic, persistent or chronic, resulting in the release 
of high titre progeny (Strauss and Strauss, 2008). 
Most alphavirus infection knowledge comes from studies of the prototype 
viruses SFV and SINV. These are prototypes viruses due to their ability to grow 
to high titres in cell culture, ability to infect cells from a broad range of hosts 
and tissue types, and the fact that their laboratory strains are nonpathogenic to 
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humans. However, the natural strains of these viruses can cause severe human 
disease (Mathiot et al., 1990; Kurkela et al., 2008). Complete cDNA clones of 
SINV and SFV have made it possible to easily manipulate the virus genomic 
sequence and transcribe infectious viral RNA in vitro (Rice et al., 1987; 
Liljeström et al., 1991). Studies of SFV and SINV have shed light on many 
aspects of the alphavirus infection cycle and also have helped to elucidate the 
basics of several cellular processes. SFV was the first virus demonstrated to 
infect cells via endocytic uptake and low pH-triggered membrane fusion, and its 
capsid protein was one of the first proteins demonstrated to exhibit 
cotranslational folding (Helenius et al., 1980; Nicola et al., 1999). In addition, 
SFV and SINV have been valuable models for studies of togavirus uptake, 
structure, replication, and cellular pathways involved in such tasks as the 
cleavage and modification of glycoproteins and their transport to the plasma 
membrane (Kääriäinen and Ahola, 2002). 
 
 
2.2. Virion and genome organisation 
 
Alphavirus virions are uniform, highly organised icosahedral particles with a 
diameter of 65–70 nm and can be described as being composed of two interacting 
protein shells with a lipid bilayer sandwiched between (Figure 1) (Jose et al., 
2009). Inside the virion, single copy of a single-stranded plus-sense RNA genome 
and 240 copies of capsid protein form the icosahedral nucleocapsid with diameter 
of 40 nm (Paredes et al., 1993; Cheng et al., 1995). The nucleocapsid is 
surrounded by a tight-fitting envelope, which consists of a host-derived lipid 
bilayer embedded with heterodimers of the viral glycoproteins E1 and E2. The 
glycoproteins penetrate the lipid bilayer and make contacts with the nucleocapsid 
by connecting each E1-E2 heterodimer to one monomer of capsid protein 
(Paredes et al., 1993; Cheng et al., 1995; Fuller et al., 1995). On the surface of the 
virion, glycoproteins form an icosahedral lattice with T=4 symmetry and three 
E1-E2 heterodimers arrange into 80 protruding structures called spikes (Vogel et 
al., 1986; Paredes et al., 1993). The receptor attachment sequence is found at the 
tip of the spike on the E2 molecule (Smith et al., 1995).  
Alphavirus genomic 42S RNA (49S for SINV) is approximately 11.5 kb 
long. The 5’ two-thirds of the genome encodes the non-structural (ns) replicase 
proteins (nsP1, nsP2, nsP3 and nsP4) and the 3’ one-third codes the structural 
proteins (Figure 1). The ns proteins are translated directly from the 42S RNA. 
Structural proteins are translated from 4.1-kb long subgenomic 26S RNA, 
which is synthesised from an internal promoter located on the minus-strand of 
the replicative intermediate. Both the 42S and 26S RNA have 5’-terminal 
methylguanylate cap-structures and 3’ polyadenylate tails (Strauss and Strauss, 
1994). 
The alphavirus genome contains three nontranslated regions (NTR): one at 
each end of the RNA and one at the junction of the non-structural and structural 
regions. All NTRs contain important structural elements, so-called conserved 
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sequence elements (CSEs) necessary for virus replication. Approximately 40 of 
the first nucleotides of the 5’ NTR form a conserved stem-loop structure 
(CSE1) and are believed to constitute the promoter for plus-strand RNA 
synthesis (Ou et al., 1983). CSE2 is located at the 5’ end of the genome within 
the nsP1 coding sequence and contains two conserved stem-loop structures that 
function to enhance both minus- and plus-strand RNA replication (Ou et al., 
1983; Frolov et al., 2001). The 24-nucleotide long basal subgenomic promoter 
(CSE3) lays at the junction of the ns and structural regions and partially over-
laps with the sequence coding for C-terminus of nsP4 (Levis et al., 1990). The 
3’ NTR contains a conserved 19-nucleotide sequence just adjacent to the 
poly(A) tail (CSE4), which is necessary for efficient minus-strand synthesis 
(Pfeffer et al., 1998; Hardy and Rice, 2005). 
 
 
 
 
Figure 1. Alphavirus virion and genome organization. The alphavirus virion contains a 
nucleocapsid formed by plus-sense single-stranded 42S RNA genome (red) and capsid 
proteins (green). The nucleocapsid is surrounded by lipid bilayer (blue) embedded with 
heterodimers of viral glycoproteins E1 and E2 (purple). The alphavirus genome contains 
open reading frames encoding for non-structural and structural proteins. The non-
structural proteins nsP1, nsP2, nsP3 and nsP4 are translated directly from the genomic 
RNA. The structural proteins C, p62, 6K and E1 are translated from the subgenomic 
RNA. p62 is the precursor of E2 and E3. 
 
 
2.3. Infection cycle 
 
2.3.1. Virus entry 
 
Alphavirus infection of a susceptible cell starts with binding to its surface 
receptor. The viral glycoprotein E2 is primarily responsible for this interaction 
(Tucker and Griffin, 1991; Salminen et al., 1992). As alphaviruses have a very 
broad host range and replicate in cells from various tissues within their hosts, 
they must use different cell surface receptors for entry or use one conserved 
receptor that is expressed ubiquitously by all susceptible cells. To date, several 
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cell surface attachment molecules have been identified, and the data suggest that 
a single alphavirus can use different types of receptors and some of these 
receptors are also shared among different alphaviruses. It has been shown that 
the ubiquitously expressed NRAMP (Natural Resistance-Associated Macro-
phage Protein, a divalent metal ion transporter) mediates the entry of SINV, but 
not RRV, both into mammalian and insect cells (Rose et al., 2011). The laminin 
receptor has been shown to mediate the entry of SINV into mammalian cells 
and entry of VEEV into mosquito cells (Wang et al., 1992; Ludwig et al., 1996). 
SINV can also use cell-type specific receptors, such as c-type lectins, for entry 
(Klimstra et al., 2003). In addition to proteinaceous receptors, nonprotein 
attachment factors, including heparin sulphate, might be used by the alpha-
viruses to aid initial binding to the host cell surface (Jose et al., 2009). To date, 
no host cell receptor has been identified for SFV. 
After binding to the receptor, virions enter host cells via clathrin-dependent 
endocytosis (Figure 2) (Helenius et al., 1980; DeTulleo and Kirchhausen, 
1998). As infection proceeds, virus-containing endosomes mature, the intra-
vesicular pH becomes mildly acidic, and this induces a series of conformational 
changes in virus glycoproteins. The E1-E2 heterodimers in the envelope are 
destabilised, and a previously hidden hydrophobic fusion loop in E1 is exposed 
(Kielian and Helenius, 1985; Wahlberg and Garoff, 1992; Ahn et al., 1999; 
Hammar et al., 2003). The fusion loop enters into the endosomal membrane and 
E1 homotrimers are formed (Wahlberg et al., 1992; Gibbons et al., 2000). This 
leads to the fusion of the viral envelope and endosomal membrane and the 
nucleocapsid is released into the cytoplasm. It has been shown that the presence 
of cholesterol and sphingolipids in the target membrane in mammalian cells is 
important for fusion (Kielian et al., 2010). The released nucleocapsid is 
disassembled by ribosomes, and viral RNA genome enters the cytoplasm (Singh 
and Helenius, 1992; Wengler et al., 1992).  
 
 
2.3.2. Genome replication 
 
The alphavirus RNA genome is capped, polyadenylated and immediately 
translated into ns polyprotein by host cell ribosomes after entry into the 
cytoplasm (Figure 2). The ns polyprotein is autocatalytically cleaved into four 
polypeptides in a precisely and temporally regulated manner to first yield the 
minus-strand synthesis complex and then transform it into stable plus-strand 
polymerase (Figure 2) (Lemm et al., 1994; Vasiljeva et al., 2003). The protease 
activity responsible for polyprotein processing resides in non-structural protein 
nsP2 (Hardy and Strauss, 1989; Merits et al., 2001). The polyprotein stage is 
essential for formation of functional replicase, as individual ns proteins cannot 
form a complex when expressed simultaneously in the same cell, whereas 
expression in a polyprotein form results in formation of complexes associated 
with cell membranes (Salonen et al., 2003). 
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Figure 2. Alphavirus infection cycle. The alphavirus virion enters the host cell by 
receptor-mediated endocytosis. The fusion of endosome and viral membranes follows and 
the viral genomic 42S RNA is released into cytoplasm. The genomic RNA is immediately 
translated into ns-polyprotein P1234 (pink) that is proteolytically processed and forms first 
the minus-strand and then plus-strand replicase. The minus-strand replicase produces 
minus-strand RNA serving as a template for new positive-strand genomic 42S and 
subgenomic 26S RNAs. The subgenomic RNA drives the expression of structural 
polyprotein that is co- and post-translationally processed. First, the capsid protein (green) 
is released and it associates with newly synthesised genomic 42S RNA to form the 
nucleocapsid. Maturation of glycoproteins (purple) occurs in ER and Golgi. Mature 
glycoproteins are transported to the plasma membrane. The nucleocapsid associates with 
glycoproteins at the plasma membrane and virion budding occurs. 
 
 
For most of the alphaviruses, the translation of the RNA genome yields two 
different polyproteins: P123 and P1234. The latter is synthesised as a result of 
translational read-through of an opal termination codon in the ns open reading 
frame with an efficiency of 10–20% (Li and Rice, 1993; Shirako and Strauss, 
1994). In some alphaviruses, including most strains of SFV, the opal 
termination codon is not present and therefore only P1234 is produced 
(Takkinen, 1986). Shortly after translation, the full-length polyprotein P1234 
likely cleaves itself in cis resulting in P123 and nsP4 to form the early 
replication complex (Figure 2). Using the genomic 42S RNA as a template, it 
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serves as a minus-strand RNA synthesis complex, which does not efficiently 
make plus-strands (Lemm et al., 1994; Shirako and Strauss, 1994; Vasiljeva et 
al., 2003). The synthesis of minus-strand RNA takes place only early in 
infection and is rapidly downregulated as the infection proceeds. Next, the 
cleavage of the polyprotein takes place between nsP1 and nsP2, and a short-
lived complex is formed by nsP1, P23 and nsP4, which can produce both plus- 
and minus-strand RNA (Lemm et al., 1998; Gorchakov, Frolova, et al., 2008). 
Shortly after that, P23 is cleaved in trans, and a stable complex is formed by the 
fully processed individual ns proteins nsP1, nsP2, nsP3 and nsP4 that constitute 
the plus-strand replication complex responsible for synthesising subgenomic 
26S and new genomic 42S RNA (Figure 2) (Lemm et al., 1994; Shirako and 
Strauss, 1994; Vasiljeva et al., 2003). The synthesis of plus-strand RNA 
continues at a maximal rate until the death of the infected cell, and over 200,000 
copies of each RNA can be made in a single cell (Sawicki and Sawicki, 1980). 
The produced subgenomic 26S RNA serves as a template for virus structural 
protein synthesis, and 42S RNA is packaged into forming virions (Figure 2). 
Among other ns polyprotein cleavage sites, the nsP2/3 site serves as an 
important temporal regulation step in the replication and infection cycle. First, it 
transforms the replicase into the plus-strand synthesis complex. Second, in later 
stages of infection, when enough nsP2 has accumulated in the cytoplasm for in 
trans cleavage, newly synthesised ns polyproteins are immediately cleaved into 
P12 and P34, and no additional functional replicases can form. Instead, ns 
polyproteins are efficiently cleaved into individual polypeptides and can fulfil 
their specific functions that are described in more detail below in chapter 2.4. 
All ns proteins are essential for viral RNA replication. Analysis of 
temperature-sensitive (ts) mutant viruses has shown that nsP1 is specifically 
necessary for minus-strand synthesis (Hahn, Strauss, et al., 1989; Lulla et al., 
2008), nsP2 regulates the synthesis of subgenomic 26S RNA (Suopanki et al., 
1998), nsP3 plays a role in minus-strand and subgenomic RNA synthesis (Sang 
1994, De 2003), and nsP4 is the catalytic subunit of the polymerase (Hahn, 
Grakoui, et al., 1989; Thal et al., 2007; Rubach et al., 2009).  
The above described fine-tuned regulation of replication most likely evolved 
to make it efficient and also to regulate virulence. For virus propagation, 
different types of replication intermediates are needed in different amounts: 
plus-strand genomic and subgenomic RNAs are required in much greater 
quantities than minus-strands. Controlled non-excessive RNA production is 
especially important in insects, where production of avirulent infection and 
minimal effect on host cell viability is needed (Jose et al., 2009).  
Alphavirus RNA replication is also a very dynamic process spatially and 
involves several different cellular compartments. This process takes place in 
association with modified intracellular membranes and the sites of replication 
are bulb-shaped membrane invaginations, called spherules (Froshauer et al., 
1988; Kujala et al., 2001). The spherules are first formed at the host cell plasma 
membrane early in infection and as infection proceeds are internalised using 
endocytic processes (Frolova et al., 2010; Spuul et al., 2010). Later in infection, 
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spherules can also be found on modified endosomal and lysosomal membranes 
in large acidic cytoplasmic vacuoles, called type I cytopathic vacuoles (CPV-1) 
(Kujala et al., 2001; Spuul et al., 2010). It has been shown that double-stranded 
replication intermediates are located inside the spherules and virus ns proteins 
forming the replicase complex can be found at the cytoplasmic necks (Kujala et 
al., 2001; Frolova et al., 2010). In addition to viral proteins, host proteins are 
likely also in close association with spherule-forming viral replication 
complexes. It has been shown that both ns polyproteins and synthesis of dsRNA 
are necessary for spherule formation (Frolova et al., 2010). The viral ns protein 
nsP1 is responsible for membrane attachment of replication complexes, and 
nsP3 is necessary for directing plasma membrane-bound replication complexes 
into intracellular vesicles (Salonen et al., 2003; Varjak et al., 2010). Possible 
reasons for membrane-associated replication and spherule formation include 
enhancing replication efficiency by bringing all the necessary components 
together in close proximity and hiding dsRNA replication intermediates from 
host cell defence systems. 
 
 
2.3.3. Virion assembly and budding 
 
Alphavirus structural proteins are translated from the subgenomic 26S RNA as 
a polyprotein, C-p62-E2-6K-E1, and processed cotranslationally by a 
combination of viral and cellular enzymes (Figure 2) (Jose et al., 2009). Capsid 
protein (C) is a serine autoprotease and cleaves itself from the nascent structural 
polyprotein (Melancon and Garoff, 1987). This cleavage releases the signal 
peptide at the new amino terminus of the polyprotein and it is inserted into the 
endoplasmic reticulum (ER), where the translation is completed and the poly-
protein is cotranslationally glycosylated, palmitoylated, and cleaved. The 
processing of the remaining structural polyprotein is mediated by a cellular 
enzyme signalase in the ER lumen and p62, 6K and E1 are produced. 
Glycoproteins p62 and E1 form heterodimers in the ER and p62 is cleaved by 
the cellular protease furin during transport from the Golgi to the plasma 
membrane to form E3 and E2 (Zhang et al., 2003). The p62-E1 heterodimer is 
more resistant to acidic conditions than the E1-E2 complex and survives the 
mildly acidic pH in transport vesicles. Once p62 is processed, the E1-E2 
heterodimer is primed for the disassembly needed during virus entry into a new 
host cell (Wahlberg et al., 1989). For some alphaviruses, including SFV, VEEV 
and CHIKV, the released E3 protein is incorporated into virions (Wu et al., 
2008; Voss et al., 2010; Zhang et al., 2011). For other alphaviruses, E3 is 
released.  
The exact function of the 6K protein remains obscure, but it might function 
in glycoprotein trafficking, virion formation and budding. It is also incorporated 
into virions in small amounts (7–30 copies) (Jose et al., 2009). Recently it was 
discovered that during SFV structural polyprotein synthesis, ribosomal frame-
shifting occurs with an efficiency of 10–18% within the sequence encoding 6K, 
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and this results in production of TransFrame (TF) protein (Firth et al., 2008). It 
has been shown that TF is packaged into virions, but its exact functions have yet 
to be determined. 
Nucleocapsids are formed in the cytoplasm of the infected cell (Figure 2). 
First, capsid protein recognises the encapsidation signal in the 42S RNA and 
then subsequent interactions between capsid proteins lead to encapsidation and 
nucleocapsid formation (Linger et al., 2004). The encapsidation signal is in the 
ns area, ensuring that only 42S, and not 26S RNA, is included into virions. In 
the SIN genome, the encapsidation signal is in the nsP1 sequence and in SFV 
RNA, the signal is in the region coding for nsP2 (Weiss et al., 1994; White et 
al., 1998). The newly formed nucleocapsids are transported or diffuse to the 
plasma membrane and are bound by cytoplasmic tails of E2 glycoprotein. 
Subsequently, nucleocapsids bud through the cell plasma membrane and acquire 
a lipoprotein envelope (Figure 2) (Jose et al., 2009).  
 
 
2.4. Non-structural proteins 
 
All four ns proteins are essential for alphavirus replication and, in addition, also 
have individual roles in the virus infection cycle and virus-host interactions. 
 
The first of the ns proteins, nsP1 (537 aa), is a membrane-binding protein 
possessing methyltransferase and guanylyltransferase activities involved in the 
capping of 42S and 26S RNAs (Mi and Stollar, 1991; Laakkonen et al., 1994; 
Ahola and Kääriäinen, 1995). In alphavirus capping reactions, nsP1 first 
transfers a methyl-group from S-adenosyl-methionine (AdoMet) to GTP, then a 
covalent intermediate complex between 7-methyl-GMP (m7GMP) and nsP1 is 
formed and m7GMP is transferred to virus RNA. The capping reaction of alpha-
viruses thus differs from the capping of cellular mRNAs, where guanylyl-
transferase first transfers GMP to RNA and then methylation of the GMP-RNA 
intermediate follows (Ahola and Kääriäinen, 1995). The enzymatic activities of 
nsP1 are essential for virus replication, as single point mutations abolishing 
enzymatic activity render the virus non-infectious (Wang et al., 1996). 
NsP1 is tightly bound to the plasma membrane in both infected cells and also 
when expressed alone and serves as the sole membrane anchor for virus 
replication complexes (Peränen et al., 1995; Ahola et al., 2000; Salonen et al., 
2003). The plasma membrane binding is mainly mediated by nsP1 amino acids 
245–264 forming an amphipathic alpha-helix (Ahola et al., 1999; Spuul et al., 
2007). Single point mutations in this area can affect nsP1 membrane binding 
activities and can be lethal to the virus (Spuul et al., 2007). The membrane 
binding is further tightened by post-translational palmitoylation at nsP1 cysteine 
residues 418–420 in SFV and cysteine 420 in SINV (Laakkonen et al., 1996; 
Ahola et al., 2000). Palmitoylation makes the nsP1 interaction with membranes 
very tight, resembling that of integral membrane proteins (Laakkonen et al., 
1996). Palmitoylation, as such, is not needed for the enzymatic activities of 
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nsP1, for formation of functional replication complexes or for the viability of 
the virus (Ahola et al., 2000; Zusinaite et al., 2007). Nevertheless, deletion or 
substitution of cysteine residues 418–420 in nsP1 of SFV greatly hampers virus 
replication and causes accumulation of compensatory mutations (Zusinaite et 
al., 2007). Viruses expressing pamitoylation-deficient nsP1 are apathogenic in 
mice; these viruses are able to induce low levels of blood viraemia, but no 
infectious virus can be detected in brain tissue (Ahola et al., 2000). 
In addition, nsP1 is also responsible for induction of filopodia-like structures 
on the cell surface that are characteristic of alphavirus-infected cells (Laak-
konen et al., 1998; Zusinaite et al., 2007). The function of filopodia-like 
structures and also the exact functional significance of palmitoylation remain 
unknown.  
 
The second ns protein, nsP2 (799 aa in SFV), has multiple enzymatic activities 
and important roles in virus infection. NsP2 is an RNA helicase and its N-
terminal domain also contains nucleoside triphosphatase and RNA triphos-
phatase activities (Rikkonen et al., 1994; Gomez de Cedrón et al., 1999; Vasil-
jeva et al., 2000). RNA helicase activity has been suggested to be important for 
unwinding RNA duplexes or RNA secondary structures during replication. 
RNA triphosphatase activity is needed during capping reactions to remove the 
5’ -phosphate from viral RNA before the guanylyltransferase activity of nsP1 
can attach the m7GMP structure.  
The C-terminal domain of nsP2 contains a papain-like protease responsible 
for processing of ns polyprotein (Hardy and Strauss, 1989; Merits et al., 2001). 
As described above, the protease participates in replication complex formation 
and the temporal regulation of replication. Mutations, which abolish proteolytic 
activity, are lethal to the virus (Strauss et al., 1992). The carboxy terminus of 
nsP2 also contains an enzymatically nonfunctional methyltransferase domain, 
which plays a role in regulation of minus-strand synthesis and development of 
cellular cytopathic effects (Mayuri et al., 2008). 
Cell fractionation studies have shown that approximately 50% of nsP2 is in 
the nuclear fraction of infected cells (Peränen et al., 1990). The transport to the 
nucleus takes place early in infection and nuclear localisation is mediated in 
nsP2 of SFV by the pentapeptide PRRRV (aa 647–651) (Rikkonen et al., 1992). 
Mutations affecting nsP2 translocation to the nucleus yield attenuated pheno-
types with reduced cytotoxicity, reduced transcriptional and translational shut-
down of host cells, and renders virus apathogenic in adult mice (Rikkonen, 
1996; Fazakerley et al., 2002; Gorchakov et al., 2005; Tamm et al., 2008). In 
addition, other sequences within nsP2, including the integrity of helicase and 
methyltransferase-like domains, are essential for mediating the virus-induced 
shutdown of cellular transcription (Gorchakov et al., 2005; Frolov et al., 2009; 
Akhrymuk et al., 2012) and suppression of antiviral responses (Frolova et al., 
2002; Gorchakov, Frolova, et al., 2008). The exact mechanism for nsP2-
mediated host cell transcription shutdown is described in chapter 2.5.1. 
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The functions of nsP3 are not well understood. The nsP3 (482 aa in SFV) 
primary structure is composed of three discrete domains. The first 160 amino 
acids of the amino terminus of nsP3 form a small structurally conserved macro-
domain, which is conserved among alphaviruses, rubella virus, hepatitis E virus, 
coronaviruses and also shares sequence similarity with the macrodomains 
displayed by proteins from eukaryotic organisms, eubacteria and archaebacteria 
(Koonin and Dolja, 1993; Pehrson and Fuji, 1998). The middle domain of nsP3 
is only conserved among alphaviruses and the C-terminal domain (starting from 
Tyr324 in SFV) is hypervariable both in sequence and length (Strauss and 
Strauss, 1994). 
In addition to localising to replication complexes, nsP3 can also be found in 
aggregates of variable size with irregular boundaries in the cytoplasm and a 
fraction of nsP3 localises to the nuclear envelope (Salonen et al., 2003; Cristea 
et al., 2006; Gorchakov, Garmashova, et al., 2008). This suggests that nsP3 has 
functions in addition to participating in RNA replication. 
The only enzymatic activity identified for nsP3 is ADP-ribose 1’’-phosphate 
phosphatase activity and it resides within the macrodomain of the protein 
(Malet et al., 2009; Neuvonen and Ahola, 2009). Alphavirus macrodomains can 
bind poly(ADP-ribose), RNA and, in some cases, ADP-ribose (Malet et al., 
2009; Neuvonen and Ahola, 2009). Interestingly, poly(ADP-ribose) polymerase 
(PARP-1) has been shown to interact with SINV replication complexes through 
the C-terminal domain of nsP3 in neuronal cells (Park and Griffin, 2009a). The 
biological significance of these functions is poorly understood.  
Based on current understanding, nsP3 is the only alphavirus ns protein 
modified by phosphorylation and gets phosphorylated at serine and threonine 
residues in the carboxy terminus (Peränen et al., 1988; Li et al., 1990; Vihinen 
and Saarinen, 2000; Vihinen et al., 2001). In SFV, all 16 identified phospho-
rylation sites are accumulated in a short 50-amino acid residue long area and 
complete elimination of these sites in nsP3 results in reduced levels of RNA 
synthesis in cultured cells and greatly reduced pathogenicity in mice (Vihinen et 
al., 2001). Studies of SINV ts mutants have shown that nsP3 phosphorylation is 
specifically important for minus-strand RNA synthesis (Dé et al., 2003). 
Studies with both SFV and SINV have also suggested a role for nsP3 in the 
modulation of neuropathogenesis in mice (Tuittila and Hinkkanen, 2003; Park 
and Griffin, 2009b). 
Studies have shown that nsP3 mediates the movement of alphavirus 
replication complexes from the plasma membrane into intracellular vesicles. 
This was elegantly demonstrated by a detailed analysis of subcellular locali-
sation of different forms of ns polyprotein intermediates. While uncleavable 
P12 localised to the plasma membrane, addition of nsP3 targeted it to endo-
somes and lysosomes (Salonen et al., 2003). 
 
The last of the ns proteins, nsP4 (614 aa in SFV), is the catalytic subunit of 
alphavirus RNA-dependent RNA polymerase (RdRP) (Hahn, Grakoui, et al., 
1989; Thal et al., 2007; Rubach et al., 2009). The C-terminus of alphavirus nsP4 
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shares sequence homology with RdRPs from other viruses and also contains the 
GDD motif observed in many viral RdRPs (Kamer and Argos, 1984). The N-
terminus of nsP4 is conserved only among alphaviruses. While nsP4 is the 
catalytic core of the replication complex, it also needs other ns proteins for 
activity (Rubach et al., 2009). Mutational studies suggest that the amino 
terminus of nsP4 mediates functional interactions with other ns proteins, parti-
cularly with nsP1, and most likely also with host proteins (Shirako et al., 2000; 
Fata et al., 2002; Rupp et al., 2011). 
The levels of nsP4 in infected cells are lower than the levels of other ns 
proteins. This is achieved by several processes. First, many alphaviruses contain 
the opal termination codon in their genome and the majority of translated ns 
polyproteins are in the form of P123, while translation of P1234 and thus also 
nsP4 happens only with 10–20% efficiency. Second, the N-terminal amino acid 
in nsP4 is a conserved tyrosine that directs nsP4 to rapid proteasomal 
degradation according to the N-end rule pathway (de Groot et al., 1991; 
Varshavsky, 1997). This destabilising tyrosine is essential, as replacing it with a 
nonaromatic residue results in poor RNA replication (Shirako and Strauss, 
1998).  
In addition, nsP4 has also demonstrated terminal adenylytransferase activity 
in in vitro experiments, suggesting a role in the maintenance and repair of the 
poly(A) tail of the viral genome (Tomar et al., 2006). The poly(A) tail is im-
portant for minus-strand synthesis and maintaining its integrity is essential for 
the virus. 
 
 
2.5. Virus-host interactions 
 
The outcome of any virus infection depends on both virus-encoded and host-
specific properties. Efficient replication of viruses in infected hosts depends on 
proper functioning of the viral replicase and synthesis of viral proteins, along 
with disruption of the host antiviral response. Therefore, alphaviruses, similar to 
many other viruses, have developed mechanisms to hamper cellular antiviral 
processes while maintaining their own genome replication and virion pro-
duction for spread in infected hosts. 
 
 
2.5.1. Shutdown of host cell transcription and translation 
 
One of the hallmarks of alphavirus infection in vertebrate cells is the shutdown 
of host cell transcription and translation without affecting the synthesis of viral 
RNAs and proteins. The transcriptional shutdown is essential to limit the 
production of antiviral proteins, mainly interferon-/ (IFN-/), that play a 
role in early innate immune response and are the first defence mechanism 
against viral infection. The secreted IFNs both attenuate the ability of virus to 
replicate in cells already infected and also protect uninfected cells from new 
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rounds of infection until the development of an adaptive immune response (Jose 
et al., 2009).  
The shutdown of cell transcription is mediated by nsP2 in Old World viruses 
and by capsid protein in New World viruses (Gorchakov et al., 2005; Gar-
mashova et al., 2006, 2007; Aguilar et al., 2007). The nsP2-mediated 
transcriptional shutdown is achieved by ubiquitination and rapid degradation of 
Rpb1, a catalytic subunit of the RNA Polymerase II complex (Akhrymuk et al., 
2012). Importantly, complete degradation of Rpb1 takes place before any other 
virus-induced change in infected cells occurs, suggesting that degradation of 
Rpb1 is the first and crucial step in the downregulation of the cellular antiviral 
response. The cellular transcription shutdown achieved by the New World virus 
VEEV is mediated through a different mechanism. The capsid protein of VEEV 
forms a complex with importin-/ and the nuclear export receptor CRM1 and 
accumulation of these complexes in nuclear pores of infected cells rapidly 
inhibits the nucleocytoplasmic trafficking of proteins, eventually leading to 
transcriptional shutdown (Atasheva et al., 2008, 2010). 
The shutdown of translation in alphavirus-infected cells is partially mediated 
by a cellular defence mechanism, the dsRNA-activated protein kinase (PKR) 
(Gorchakov et al., 2004, 2005). The presence of viral dsRNA activates host 
PKR, which phosphorylates and transiently inactivates the eIF2 subunit of 
cellular translation initiation factor eIF2. eIF2 is responsible for delivering 
initiator methionyl-tRNA to ribosomes and is essential for translation initiation. 
The phosphorylation of eIF2 results in a significant decrease in cellular 
translation, but the translation of alphavirus subgenomic RNA does not depend 
on eIF2 (Ventoso et al., 2006). Several alphaviruses, including SINV and 
SFV, have evolved a unique mechanism to bypass the requirement for eIF2 
through the presence of a highly stable RNA hairpin loop downstream of the 
AUG initiator codon in 26S RNA, also called an enhancer sequence, which 
likely functions by stalling the ribosomes on the correct site to initiate trans-
lation (Sjöberg et al., 1994; Frolov and Schlesinger, 1996; Ventoso et al., 2006). 
Another pathway leading to eIF2 phosphorylation and translation shutdown 
in alphavirus-infected cells is the unfolded protein response in the ER 
(Nivitchanyong et al., 2009; Barry et al., 2010). Studies have shown that one of 
the major ER stress sensors, eIF2 kinase 3 (PERK), is activated upon SINV 
infection leading to eIF2 phosphorylation (Nivitchanyong et al., 2009). The 
alphavirus glycoproteins E1 and E2 are translated and processed in the ER and 
Golgi and likely exceed the ER folding capacity, resulting in induction of the 
unfolded protein response.  
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2.6. Infection of the nervous system 
 
SFV and SINV are Old World alphaviruses, but in rodents they cause 
encephalitis and therefore have been extensively used as models for alphavirus-
induced neurological disease and acute viral encephalitis in general. The 
pathogenesis of alphavirus infection in the central nervous system (CNS) 
depends both on host age and virus strain, which together determine if the 
infection is restricted or widespread, and whether cells die, clear the virus, or 
become persistently infected (Fazakerley, 2002; Griffin, 2005). 
Virus inoculation into the abdominal cavity (intraperitoneal inoculation, i.p.) 
is the most commonly used route to study the neuroinvasivness of alphaviruses. 
SFV and SINV inoculated i.p. first replicate in a number of tissues, resulting in 
high titre plasma viraemia that can be detected by 24–48 hours post-infection 
and is generally undetectable by day 4 (Fazakerley, 2002). High titre plasma 
viraemia is a prerequisite to infect the CNS and, in nature, also crucial for 
efficient transmission of virus to insect vectors during a blood meal. After entry 
into the CNS, alphaviruses first establish small perivascular foci of infection 
and in cases of permissive hosts, widespread replication in the CNS follows 
(Fazakerley et al., 1993). The cell types infected in the brain are mainly neurons 
and in case of SFV, also oligodendrocytes (Fazakerley, 2002). 
All strains of SFV and SINV productively infect neonatal and young 
suckling mice (up to 11 days old). They replicate efficiently in the CNS, induce 
apoptotic death of infected cells, and animals die rapidly within couple of days 
(Fazakerley, 2002; Griffin, 2005). However, the outcome of infection in older 
mice can range from avirulent infection to lethal encephalitis depending on the 
virus strain used. The L10 strain of SFV efficiently causes lethal encephalitis in 
adult mice by any route of inoculation (Gates et al., 1985; Fazakerley et al., 
1993; Oliver et al., 1997). The prototype strain SFV4 is neurovirulent and 
efficiently causes lethal encephalitis after intracerebral (i.c.) inoculation. An i.p. 
course of infection with SFV4 is productive only when high doses of virus are 
used; low doses fail to establish high titre plasma viraemia and the virus does 
not efficiently enter the CNS (Tarbatt et al., 1997; Tuittila et al., 2000; 
Fragkoudis et al., 2007). The SFV A7 and A7(74) strains are apathogenic in 
mice older than 2 weeks (Gates et al., 1985; Fazakerley et al., 1993; Oliver et 
al., 1997). SFV A7(74) is neuroinvasive in adult mice and efficiently enters the 
CNS when inoculated i.p. even at low doses, but infection is apathogenic and 
spread in the CNS remains limited and concentrated to perivascular foci. 
Replication is severely restricted in CNS neurons, and the virus is cleared from 
the brain (Fazakerley et al., 1993; Oliver et al., 1997). Interestingly, when SFV 
A7(74) is administered i.c. it still remains avirulent and restricted in mature 
neurons, but widespread replication in oligodendrocytes in the major white 
matter tracts can be observed (Fazakerley et al., 2006). Age-dependent 
susceptibility to fatal disease has also been described for SINV (Labrada et al., 
2002; Griffin, 2005). It should also be noted that many other neurotrophic 
viruses cause more severe disease and replicate to higher titres in neonatal mice 
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than in older animals, and often the sharp decrease in susceptibility to fatal 
infection is during the first two weeks of life (Griffin, 2005).  
The molecular determinants of increased susceptibility of younger hosts to 
severe alphavirus-induced encephalitis remain poorly understood. Studies with 
mice having selective immune dysfunctions suggest that it is not dependent on 
maturation of innate or adaptive immune responses, but rather on the maturity 
of neurons and neuronal circuits (Fazakerley et al., 1993; Oliver et al., 1997). 
For example, infection of SFV A7(74) remains restricted in mature neurons in 
athymic nu/nu mice lacking functional T-lymphocytes and even in mice with 
severe combined immunodeficiency (SCID) lacking both T- and B-lymphocytes 
(Fazakerley et al., 1993; Oliver et al., 1997). Restriction of replication in mature 
neurons is not mediated by the type-I IFN system (IFN-/) either (Fragkoudis 
et al., 2007). These results indicate that intrinsic properties of neurons and 
neuronal networks are important in determining the neuropathogenicity of 
alphavirus infection. 
During the first postnatal weeks, when the susceptibility to fatal encephalitis 
declines, several changes take place in the mouse CNS. It is a time when 
detailed connections in neuronal network are finalised and axogenesis, 
synaptogenesis, gliogenesis and myelination are being completed (Fazakerley, 
2002; Griffin, 2005). While apoptosis of immature neurons is part of normal 
development of the nervous system and immature neurons depend on trophic 
factors for survival, as neurons mature they become less dependent on growth 
factors and survival signalling pathways dominate (Fazakerley, 2002; Griffin, 
2005). Mature neurons are irreplaceable and apoptosis or death of these cells 
can have severe consequences to the host. Upregulation of antiapoptotic 
pathways might restrict alphavirus infection in mature neurons. In mature 
neurons, the metabolic processes are also downregulated, and the production 
and transport of smooth membrane vesicles needed for alphavirus replication is 
decreased. In agreement with this theory, when gold compounds, which induce 
smooth membrane production in neurons, are administered to adult mice before 
infection, SFV A7(74) spreads efficiently in the mature CNS and neurons 
become permissive to replication (Scallan and Fazakerley, 1999). 
 
 
2.6.1. Immune response in the mouse CNS 
 
The immune response in the CNS is tightly regulated and depends on 
interactions between neurons and glial cells, blood brain barrier (BBB) function 
and constitutive production of regulatory molecules. Microglial cells represent 
the macrophage lineage in the CNS and their functions are inhibited by specific 
neurons under normal conditions. As part of normal immunologic surveillance, 
activated T cells cross the BBB and if antigen is not found they leave or die 
(Griffin and Metcalf, 2011). 
When the CNS is infected, a rapid response follows. The exact mechanism 
for sensing alphavirus infection is not yet known, but likely toll-like receptors 
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and intracellular RNA helicases sensing the viral dsRNA are involved (Griffin 
and Metcalf, 2011). The type-I interferon system is important for initial control 
of alphavirus infection and both humoral and cellular arms of adaptive immune 
response participate in elimination of the virus. Following alphavirus infection 
type-I interferons are rapidly induced and the levels correlate with the virus titre 
in blood and viral RNA in the brain (Bradish et al., 1972; Fragkoudis et al., 
2007). Virus strains apathogenic in wild-type mice are virulent and induce 
widespread infection in IFNAR-/- animals lacking functional IFN-/ receptors 
(Hwang et al., 1995; Ryman et al., 2000; Fragkoudis et al., 2007). 
Recovery of adult mice from infection with avirulent alphavirus strains 
requires immune-mediated clearance of the virus. Infection with avirulent 
strains is cleared from the brain in 7 to 10 days post-inoculation and it is a 
nonlytic process requiring both, functional T- and B-lymphocytes (Fazakerley, 
2002; Griffin, 2005). In mice, which lack functional B-cells (MT mice), 
clearance of SFV A7(74) is impaired both in blood and brain, while in mice, 
which lack functional T-cells (nu/nu mice), the viraemia is transient but CNS 
infection is persistent (Amor et al., 1996; Fragkoudis et al., 2008). Interestingly, 
avirulent strains of both SFV and SINV can establish persistent CNS infection 
in immunocompromised nu/nu or SCID mice, while no evidence of pathology 
can be detected (Amor et al., 1996). 
The infectious virus is cleared very rapidly from CNS while the levels of 
viral RNA decrease gradually during several weeks in infected mature neurons 
(Metcalf and Griffin, 2011). As infected mature neurons are irreplaceable and 
cannot be eliminated without possible severe consequences, viral RNA cannot 
be completely cleared and long-term persistence of low levels of viral RNA in 
surviving cells has been described (Levine and Griffin, 1992; Fragkoudis et al., 
2008; Metcalf and Griffin, 2011). Both antibody secreting cells and IFN- are 
essential for prevention of viral reactivation after viral clearance (Burdeinick-
Kerr et al., 2007).  
In adult mice, SFV A7(74) infection occasionally results in transient inflam-
matory demyelination of axons and the most likely mechanism generating these 
lesions is CD8+ T-cell-mediated elimination of infected oligodendrocytes 
(Subak-Sharpe et al., 1993; Amor et al., 1996).  
 
 
2.7. Alphavirus-based vectors 
 
Alphavirus-based vectors expressing marker proteins, which are easy to 
visualise or quantify, have been successfully used to study virus infection both 
in cell culture and in animal models. Recombinant viruses expressing various 
host proteins have helped to analyse the effect of these proteins on the viral 
infection cycle. Although most viral vectors used for medical or biotechnology 
purposes are based on viruses with DNA genomes or retroviruses, vectors based 
on RNA viruses, including alphaviruses, have shown promising results. The 
main advantages of alphavirus-based vectors over DNA or retrovirus-based 
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systems are the high-level expression of foreign gene, cytoplasmic replication 
and no danger of integration of virus genetic material into host cell genome. 
Other characteristics of alphavirus-based vectors are the ability to replicate in a 
broad host cell range, high cytotoxicity and apoptotic rate of infected cells, very 
high but short-term foreign gene expression, and very high induction of the 
type-I interferon response. As alphavirus-based vectors mediate transient 
expression, the main applications that have been investigated are recombinant 
vaccine construction, treatment of CNS diseases and anti-cancer therapy (Atkins 
et al., 2008). 
Infectious cDNA clones have been developed for many alphaviruses, in-
cluding SFV, SINV, EEEV, VEEV, CHIKV and RRV (Atkins et al., 2008). 
Alphavirus-based vectors contain a cDNA copy of the entire viral genome 
inserted downstream of a bacteriophage RNA polymerase promoter, usually 
from bacteriophage SP6 or T7. In vitro transcribed RNA introduced into 
mammalian cells initiates the infectious cycle and infectious virus is produced. 
Alternatively, strong promoters working in eukaryotic cells can be successfully 
used to drive the expression of infectious virus RNA from a DNA plasmid 
transfected into mammalian cells (Atkins et al., 2008). 
The first alphavirus-based vector constructed was the recombinant virus-like 
particle (VLP), also called a “suicide” particle vector (Figure 3A) (Liljeström 
and Garoff, 1991). In this design, the virus structural genes are deleted or 
substituted with foreign genes, but all the sequences needed for efficient 
replication remain. The structural proteins are provided in trans by helper RNAs 
that encode the capsid or envelope proteins but lack the packaging signal 
(Frolov et al., 1996; Smerdou and Liljeström, 1999). Introduction of in vitro-
transcribed helper RNAs along with vector RNA into packaging cells will result 
in efficient replication of both and formation of VLPs from structural proteins 
translated from subgenomic RNA made from the helper RNA templates. The 
formed suicide particles are able to infect susceptible cells but can only go 
through one round of efficient replication. However, these vectors are mostly 
valuable for gene and biotechnology purposes and generally not suitable for 
studies of alphavirus infection where spreading and propagation of virus is 
important.  
Double-subgenomic alphavirus-based vectors are also very commonly used. 
In this design, sequences encoding virus proteins are left intact and a duplicated 
subgenomic promoter is introduced to guide the expression of the foreign gene 
(Figure 3B) (Frolov et al., 1996; Atkins et al., 2008). To mimic the expression 
of virus structural proteins and also increase the levels of foreign protein, a 
translation enhancer element from the capsid protein can be used upstream of 
the foreign gene (Sjöberg et al., 1994; Smerdou and Liljeström, 1999; Ventoso 
et al., 2006). Double-subgenomic vectors enable direct observation of infection 
and have been successfully used to study alphavirus pathogenesis in animals, 
the entry and spread of the virus in the CNS, virus cell tropism and virus-host 
interactions (Levine et al., 1996; Cook and Griffin, 2003; Vähä-Koskela et al., 
2003; Toribio and Ventoso, 2010). However, these vectors tend to suffer from 
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genomic instability, most likely due to recombination events between 
duplicated sequences and because the foreign gene is introduced as an 
independent transcription unit and has no selective value for the virus 
(Pugachev et al., 1995, 2000; Thomas et al., 2003). In addition, introducing a 
second subgenomic promoter slows down virus replication and reduces the 
levels of structural proteins by competition with the native subgenomic 
promoter for viral transcriptase complexes (Raju and Huang, 1991; Thomas et 
al., 2003). One solution to alleviate the genomic instability is the use of an 
internal ribosomal entry site (IRES) instead of a duplicated subgenomic 
promoter. This strategy was successfully utilised in Rubella virus and VEEV 
vectors, but for unknown reasons works poorly in the case of SFV (Pugachev et 
al., 2000; Volkova et al., 2008; Rausalu et al., 2009).  
Another possibility is to insert foreign sequences into virus ns or structural 
polyprotein coding sequences so that the foreign sequence becomes a part of the 
viral gene expression unit (Figure 3C, D). These vectors should have higher 
genomic stability and marker expression mimics that of viral proteins, which is 
not always achieved when independent transcriptional units are used. Design of 
these vectors is more difficult as correct expression, processing and final 
conformation to ensure functionality of virus ns and structural proteins is 
essential for virus viability. 
 
 
 
 
Figure 3. Alphavirus-based expression vectors. (A) Virus-like particle vectors. In the 
replication-competent vector, the structural genes are substituted with foreign genes. 
Virus structural proteins needed for particle formation are provided by helper vectors. 
(B) Double-subgenomic vectors contain a duplicated subgenomic promoter for foreign 
gene expression. (C) Foreign protein is expressed in fusion with virus ns proteins. (D) 
Foreign protein is expressed as a cleavable component of the viral structural 
polyprotein. Capsid mediates the C-terminal and inserted 2A peptide the N-terminal 
cleavage of foreign protein from the polyprotein. 
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SINV genomes with markers inserted into ns polyprotein to produce nsP2- or 
nsP3-fusion proteins have been described (Figure 3C) (Bick et al., 2003; 
Frolova et al., 2006; Atasheva et al., 2007). Luciferase or green fluorescent 
protein (GFP) coding sequences have been successfully inserted into the nsP3 
hypervariable area without affecting the infectivity or replication of the virus. 
Luciferase enabled quantification of the production of viral ns proteins in 
infected cells and GFP was used to purify nsP3-containing complexes and 
visualise their time-dependent dynamics in infected cells (Bick et al., 2003; 
Frolova et al., 2006). To find suitable areas in nsP2 for marker insertion, a 
transposon-based approach was used to generate a cDNA library of SINV 
genomes with GFP randomly inserted into nsP2. Several sites within nsP2 were 
identified that tolerated insertions and resulted in viable virus presenting only 
slightly slower growth kinetics than wild-type virus (Atasheva et al., 2007). 
These insertions generated important information about functional domains in 
nsP2 and recombinant viruses expressing GFP in fusion with nsP2 have been 
successfully used to purify nsP2-containing complexes from infected cells. 
Recently, several studies have also used SFV-based vectors expressing nsP3-
marker fusion proteins to monitor the detailed dynamics of replication 
complexes in living mammalian cells or to study the antiviral response in 
mosquito cells (Spuul et al., 2010; Siu et al., 2011).  
The production of marker proteins as part of the viral ns polyprotein has also 
been successful for other plus-strand RNA viruses. For example, recombinant 
Hepatitis C virus expressing EGFP has been used to visualise virus replication 
complexes and recombinant Equine arteritis virus has been used to facilitate 
testing of antiviral compounds in infected cultured cells (Moradpour et al., 
2004; van den Born et al., 2005). 
A marker gene has been successfully introduced as a cleavable component 
also into SINV structural polyprotein between sequences coding for capsid and 
E3 proteins (Figure 3D) (Thomas et al., 2003). The carboxy terminal release of 
foreign protein from the virus structural polyprotein was mediated by an 
introduced 2A peptide from foot and mouth disease virus (FMDV). N-terminal 
cleavage was mediated by capsid protein. The resulting viruses replicated 
efficiently in cultured cells, had high genomic stability and presented mortality 
rates comparable to their parental strain in new-born mice (Thomas et al., 
2003). 
 
 28
3. RESULTS AND DISCUSSION 
 
Objectives of the present study 
 
Recombinant viruses expressing marker proteins easy to visualise, trace, or 
quantify have facilitated virus infection studies in both cultured cells and in 
animals. The aim of the present study was to design novel recombinant SFV-
based viruses stably expressing marker proteins and to use these viruses to 
study different aspects of SFV infection in cell culture and animal models. 
 
1. Design recombinant viruses expressing marker proteins with stable 
genomes suitable for infection studies in cell cultures and animal models.  
2. Determine the genetic stability and infection properties of recombinant 
viruses in cultured cells. 
3. Use suitable marker-expressing viruses to study the course of infection 
and neuropathogenesis of SFV in adult mouse brain and cultured neurons 
4. Study the effects of nsP1 and its palmitoylation-deficient form on host 
cells and the SFV infection cycle. 
 
 
 
3.1. Design and characterisation  
of novel marker viruses (I, II) 
 
3.1.1. Design of novel marker viruses 
 
We investigated the possibilities of expressing the marker protein as part of 
both SFV ns and structural polyproteins. We hypothesised this would result in 
stable marker expression accurately reflecting the activities of viral genomic 
and subgenomic promoters during infection. All these properties are crucial for 
a good recombinant virus suitable for both in vitro studies with cell cultures and 
in vivo mouse pathogenesis experiments. As marker insertion into a virus 
transcriptional unit could have possible negative effects on virus viability, 
replication, polyprotein processing and virion formation, we analysed the 
infection properties of recombinant marker viruses in detail in cultured cells 
before pathogenesis studies.  
In our first recombinant virus design, we investigated the possibility of 
inserting the coding sequence of EGFP into non-structural area of virus 
genome, specifically into the nsP3 coding region, to produce an nsP3-EGFP 
fusion protein (I, Fig 1a). The resulting recombinant virus SFV4(3F)-EGFP was 
viable, expressed the nsP3-EGFP fusion protein at the expected size (I, Fig. 2a) 
and produced punctuate cytoplasmic EGFP fluorescence that colocalised with 
nsP3 in infected cells (I, Fig. 1c). However, both plaque purification and 
Western blot analysis revealed that SFV4(3F)-EGFP was genetically highly 
unstable.  
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In SFV4(3F)-EGFP, the marker was inserted into the hypervariable domain 
of nsP3, before the last 30 amino acid residues of the carboxy terminus. In 
addition, two recombinant SINVs with marker insertion into two different 
locations within the hypervariable domain of nsP3, distinct from the position 
used in SFV4(3F)-EGFP, have been described (Bick et al., 2003; Frolova et al., 
2006). While one resulting recombinant SINV was successfully used and 
harboured a stable genome, the second virus was unstable (Bick et al., 2003; 
Frolova et al., 2006). Both our and previously published results indicate that the 
reportedly unstructured carboxy terminus of nsP3 is sensitive to insertions into 
certain positions and most likely contains linear sequence elements important 
for the viral life cycle. In agreement with this hypothesis, data published after 
completion of our studies indicated that the area we used for marker insertion 
lies within a conserved element playing a critical role in virus replication cycle 
(Varjak et al., 2010). Marker insertion in SFV4(3F)-EGFP into this conserved 
element most likely disrupted its functionality causing defects in formation and 
functioning of replication complexes or affecting other functions of nsP3. 
We concluded that, similar to SINV nsP3-fusion constructs (Bick et al., 
2003; Ryman et al., 2005; Frolova et al., 2006; Ventoso et al., 2006) SFV4(3F)-
EGFP could be useful for studying replicase gene expression, replicase protein 
localisation and interactions in cell cultures, but its instability hampers the use 
of the construct for in vivo pathogenesis studies. 
To eliminate the possible negative effect of the nsP3-EGFP fusion protein on 
virus life cycle, new recombinant viruses were designed that produce marker 
protein that is cleaved from nsP3 and nsP4 by a viral protease. Starting with 
SFV4(3F)-EGFP, we restored the native C-terminus of nsP3 and inserted an 
optimised artificial nsP2 protease cleavage site between nsP3 and EGFP (I, Fig. 
1a). The introduced nsP2 cleavage site was based on an original nsP3/4 site that 
is the most efficiently cleaved site in the SFV ns polyprotein (Lulla et al., 2006). 
The resulting virus, designated SFV4(3H)-EGFP, was viable and had similar 
infectivity to parental SFV4, as determined by infectious centre assay. Impor-
tantly, in the SFV4(3H)-EGFP-infected cells, EGFP had diffuse cytoplasmic 
and nuclear staining, and no colocalisation with nsP3 could be seen (I, Fig. 1d). 
These results indicate that EGFP was efficiently released from the viral ns 
polyprotein and not incorporated into virus replication complexes. In addition, 
Western blot analysis demonstrated the presence of individual nsP1, nsP2, nsP3, 
nsP4 and EGFP proteins in infected cells (I, Fig. 2a). 
To enable easy monitoring of structural protein synthesis, we also in-
vestigated the possibility of expressing marker protein as part of virus structural 
polyprotein. We constructed a recombinant SFV with the EGFP inserted 
between sequences coding for capsid and glycoproteins, similar to previously 
described recombinant SINV (Thomas et al., 2003). In this design, the EGFP 
should be released from the viral structural polyprotein cotranslationally by N-
terminal cleavage by the capsid protein and the C-terminus is released by an 
inserted 2A peptide from FMDV (II, Fig. 1a). The resulting recombinant virus, 
designated SFV4-stEGFP, was viable and efficiently expressed marker protein. 
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Structural polyprotein of the new virus was efficiently processed to release both 
free capsid and free EGFP. Low levels of high-molecular mass proteins 
containing EGFP could also be detected, indicating that some EGFP remained 
attached to glycoproteins in an EGFP-2A-p62 form (II, Fig. 1c). The 
explanation for this could be that the 2A peptide function was not 100% 
efficient. 
 
 
3.1.2. Characterisation of novel  
marker viruses in cultured cells (I, II) 
 
One-step growth curves demonstrated that both SFV4(3H)-EGFP and SFV4-
stEGFP replicated to high titres in BHK-21 cells (I, Fig. 1b; II, Fig. 1e). 
Relative to parental SFV4, accumulation of recombinant viruses was slightly 
delayed and SFV4-stEGFP was more attenuated in growth than SFV4(3H)-
EGFP. However, as both marker viruses were able to replicate to high titres 
within 10 h (109 pfu/ml), we concluded that insertion of EGFP into virus 
polyproteins had only a mild effect on viral life cycle in cultured cells. 
The slower growth of SFV4(3H)-EGFP is most likely mainly caused by 
increased time needed for replication of the longer genome. In agreement with 
this, the viral RNA synthesis in SFV4(3H)-EGFP-infected cells had a similar 1 
h delay as seen in growth curves when compared to parental SFV4 (I, Fig. 3a). 
The more attenuated phenotype observed for SFV4-stEGFP could, in addition 
to the longer genome, be due to reduced efficiency in structural polyprotein 
processing as evidenced by the presence of small amounts of unprocessed 
EGFP-2A-p62 (II, Fig. 1c). This could have affected both glycoprotein 
trafficking and virion assembly. In addition, proteins encoded before the 2A 
sequence in the polyprotein can be found in molar excess over proteins C-
terminal to the 2A (Donnelly et al., 2001). If this also happens in SFV4-
stEGFP-infected cells, then the virus glycoproteins are produced in lower 
amounts than capsid protein, most likely affecting efficient virion formation. 
As correct ns polyprotein processing is essential for functional replication 
complex formation and marker insertion within the replicase region could 
significantly affect this process, we studied the dynamics of ns polyprotein 
processing in detail in SFV4(3H)-EGFP-infected cells. We could not detect any 
apparent disturbance of processing besides the presence of very small amounts 
of EGFP-nsP4 fusion protein (I, Fig. 2a). The lack of nsP3-EGFP indicates the 
introduced optimized cleavage site between nsP3 and EGFP is very efficiently 
processed. As released EGFP-nsP4 can be only cleaved in trans, its 
accumulation indicates that the 3/4 site is more efficiently cleaved in cis and 
most likely less so in trans. Although it is generally believed that in SFV-
infected cells, the first cleavage in ns polyprotein processing between nsP3 and 
nsP4 takes place in cis, in cell-free reaction conditions used to study polyprotein 
processing, the requirements only for in trans cleavage have been successfully 
elucidated (Vasiljeva et al., 2003; Lulla et al., 2006). Our results indirectly 
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support the hypothesis of in cis cleavage of the 3/4 site in the ns polyprotein 
during replication complex formation in SFV-infected cells and represent, to 
our knowledge, the best available proof for it. 
Interestingly, our data also indicate that addition of a fourth cleavage site in 
the ns polyprotein did not dramatically change the dynamics of processing nor 
affect functioning of the replicase. The full significance of this fact is not clear, 
but it does highlight the specific role of 3/4 site processing in the alphavirus life 
cycle. Although we did not attempt to use a similar approach to place marker 
genes between nsP1/nsP2 or nsP2/nsP3, it is rather likely that these mani-
pulations would have had a major impact on replicase maturation and resulted 
in defective, possibly non-infectious genomes. 
SFV is an arbovirus and its infection cycle in nature involves apathogenic 
replication in blood-sucking insects. We demonstrated that in addition to 
mammalian BHK-21 cells, both SFV4(3H)-EGFP and SFV4-stEGFP efficiently 
infected and replicated in a mosquito cell line C6/36 (II, Fig. 2). Cells infected 
with SFV4(3H)-EGFP and SFV4-stEGFP efficiently expressed EGFP that did 
not colocalise with viral replication complexes, indicating proper polyprotein 
cleavage. Similar to the parental SFV4, no cytopathic effect was induced in 
infected C6/36 cells. 
 
 
3.1.3. Genetic stability of recombinant viruses  
in vitro and in vivo (II) 
 
The genetic stability of SFV4(3H)-EGFP and SFV4-stEGFP was determined by 
passaging viruses five times through BHK-21 cells or adult mouse brains (II, 
Table 1). Usually the genetic stability of a recombinant viruses is evaluated by 
methods that are not very sensitive and do not enable quantitative measurements 
(Pugachev et al., 1995; Thomas et al., 2003). We wanted to also detect small 
changes in the virus population and employed a more sensitive technique to 
quantify the genetic stability of recombinant viruses - plaque purification 
followed by monitoring of EGFP fluorescence produced by purified virus 
isolates. Using this approach, we demonstrated that upon passage in BHK-21 
cells, SFV4(3H)-EGFP had significantly increased genomic stability relative to 
the above-described SFV4(3F)-EGFP. After five consecutive passages of 
SFV4(3H)-EGFP, more than 90% of plaques analysed were EGFP-positive (II, 
Table 1). However, SFV4-stEGFP demonstrated increasing instability upon 
passage in BHK-21 cells (II, Table 1).  
The in vitro propagated and plaque-purified SFV4(3H)-EGFP isolates 
presenting the EGFP-negative phenotype were analysed. We identified large in-
frame deletions or elimination of the entire EGFP marker gene with all 
duplicated sequences in their genomes. This indicates that mutations shortening 
the virus genome give a slight growth advantage and thus accumulate in the 
virus population. Our attempts to further increase the genomic stability of 
SFV4(3H)-EGFP by removing 6 duplicated amino acids from the N-terminus 
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EGFP or by decreasing the length of duplicated nsP3 sequence added to the C-
terminus of EGFP resulted in viable virus, but genetic stability was not 
increased. 
Importantly, both SFV4(3H)-EGFP and SFV4-stEGFP presented very high 
genetic stability upon in vivo passage through adult mouse brains (II, Table 1). 
In the case of both recombinant viruses, after the fifth consecutive passage, 
more than 90% of analysed plaques were expressing functional EGFP. From 
this data we concluded that both recombinant viruses were suitable for further 
mouse pathogenesis experiments.  
The significant differences between in vitro and in vivo stability could be 
due to the different cellular environments and differences in virus amounts used. 
While mice received 1000 pfus of virus for passaging, about 100-fold more 
virus was used to infect cultured cells for each passage. Due to the use of a 
higher amount of infectious virions for each passage, it is more likely that 
mutant viruses with deletions in marker-encoding region are included into 
inoculums. It is also possible that the growth advantage of viruses with marker 
deletions in mouse brains were less pronounced than in cultured cells. 
 
 
3.1.4. NsP3 carboxy terminus contains  
a hypothetical degradation signal (I) 
 
In BHK-21 cells infected with SFV4(3H)-EGFP, the EGFP signal monitored by 
fluorescence microscopy could be detected as early as 2 h post-infection. The 
signal increased until 6 h and then decreased rapidly. In general, EGFP is a 
stable protein with an estimated half-life of 24 h and once expressed should be 
detectable for longer than 24 h. Thus, the rapid decrease of EGFP signal in 
infected cells suggested possible low stability of the virus-encoded marker 
protein. To assess EGFP stability, infected cells were metabolically labelled, 
chased and subsequently EGFP, nsP1 and nsP3 were immunoprecipitated. 
While only a small decrease in nsP1 and nsP3 signal could be detected over a 
24 h period, the levels of EGFP had decreased significantly already during 3 h 
chase-period and the estimated half-life of the marker protein was less than 2 h 
(I, Fig. 2b). These results demonstrated that the EGFP encoded by SFV4(3H)-
EGFP is significantly destabilised and we suggested that additional amino acid 
residues in the amino or carboxy terminus of virus-encoded EGFP must be 
responsible for its rapid degradation. The N-terminal amino acid residue of 
processed EGFP expressed by SFV4(3H)-EGFP is a Gly, a stabilising residue 
according to the N-end rule (Varshavsky, 1997). This suggests that the 
destabilising sequence must be at the C-terminus. In the processed EGFP, 30 
amino acid residues from the carboxy terminus of nsP3 are fused to the EGFP 
C-terminus and we hypothesised that this must contain destabilising sequences. 
Indeed, further detailed analysis performed by another member of our lab 
identified strongly destabilising sequences within the C-terminal ends of nsP3 
proteins from both SFV and SINV (Varjak et al., 2010). 
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We also studied the half-life of EGFP expressed in SFV4-stEGFP-infected 
BHK-21 cells and determined it to be a stable protein (II, Fig. 1d). The 
unexpected differences in the stability of EGFP expressed by these recombinant 
viruses makes them excellent tools in infection studies. The short half-life of 
EGFP expressed by SFV4(3H)-EGFP is very useful because fluorescence 
intensity closely reports ns polyprotein synthesis. EGFP can be monitored early 
in infection and its levels rapidly decrease when synthesis of ns polyprotein is 
downregulated. EGFP expressed in SFV4-stEGFP-infected cells can be detected 
later in infection, as virus structural polyprotein synthesis starts and the fluore-
scence levels remain high until the death of the cells. Thus, the protein is a 
reliable marker for detection of all infected cells in the later stages of infection. 
 
 
3.2. Course of infection  
of recombinant viruses in adult mice (II) 
 
In adult mice, the two most studied SFV strains, SFV L10 and SFV A7(74), are 
virulent and avirulent, respectively. The prototype strain SFV4 used in this 
study to design recombinant viruses is neurovirulent by intranasal or i.c. ino-
culation but does not efficiently reach the CNS by i.p. inoculation (Fazakerley, 
2002; Fragkoudis et al., 2007). To assess the virulence and neuroinvasion of 
EGFP-expressing marker viruses, both i.p. and i.c. routes of inoculation were 
used. 
SFV4, SFV4(3H)-EGFP and SFV4-stEGFP were all avirulent in adult 
Balb/c mice following i.p. inoculation. Infected mice were monitored for 2 
weeks and remained healthy even when high doses of viruses (5*105 pfu) were 
used. The extraneural replication of SFV4(3H)-EGFP was identical to parental 
SFV4, while SFV4-stEGFP replication was significantly attenuated. By 24 h 
post-inoculation, SFV4(3H)-EGFP had induced plasma viraemia at similar 
levels to SFV4, but no infectious virus could be detected at this time in the 
blood of mice infected with SFV-stEGFP (II, Fig. 3a). Neither the parental 
SFV4 nor recombinant viruses were neuroinvasive, and no infectious virus or 
any EGFP fluorescence signal could be detected in brains at 4 days post-
infection (II, Fig. 3b). 
To determine if recombinant viruses were neurovirulent and could replicate 
in the brain as efficiently as the parental SFV4, an i.c. route of inoculation was 
used. SFV4(3H)-EGFP presented a strong neurovirulent phenotype, similar to 
parental SFV4, but SFV4-stEGFP was slightly, but clearly, attenuated. Animals 
infected with SFV4 or SFV4(3H)-EGFP reached clinically determined end 
points, indicative of substantial disease by 2 days post-inoculation. The course 
of infection in SFV4-stEGFP-infected mice was slower and mice reached 
clinically defined end points by 3 days post-inoculation. The recombinant 
SFV4(3H)-EGFP replicated efficiently in the CNS and induced high levels of 
infectious virus in the brain, similar to SFV4 (II, Fig. 3c). The SFV4-stEGFP 
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was slightly attenuated and the induced CNS titres were approximately 10-fold 
lower than in case of SFV4 or SFV4(3H)-EGFP (II, Fig. 3c). 
We concluded that the course of infection with SFV4(3H)-EGFP was 
indistinguishable from parental SFV4. The SFV4-stEGFP had a slightly 
attenuated phenotype but nevertheless remained neurovirulent and the course of 
infection was in general similar to parental SFV4 and distinct from other strains 
of SFV, SFV L10 and SFV A7(74) (II, Fig. 3). 
The slightly attenuated phenotype of SFV4-stEGFP in adult mice could be 
caused by accumulation of small amounts of unprocessed EGFP-2A-p62 or 
non-equimolar synthesis of glycoproteins and capsid, as described above in 
chapter 3.1.2. Previous studies have indicated that recombinant SINV 
expressing foreign proteins as part of the virus structural polyprotein presented 
slightly attenuated phenotypes. In these experiments, subcutaneous inoculation 
of newborn mice with recombinant SINV resulted in 100% mortality, similar to 
parental strain, but the average survival time was increased by 2–3 days 
(Thomas et al., 2003). In the case of recombinant SINV, the structural poly-
protein was reported to be properly processed. 
During this study, we also inoculated mice with the SFV L10 and SFV 
A7(74) strains in parallel with SFV4 and SFV4-based marker viruses. The 
obtained data provided some general insights into the pathogenesis of SFV. We 
observed that SFV4 induces approximately 1000-fold lower plasma viraemia 
than SFV L10 or SFV A7(74) following i.p. inoculation (II, Fig. 3a). In 
agreement with previously published data, we also observed that SFV4 is not 
efficiently neuroinvasive following low dose i.p. inoculation, while SFV L10 
and SFV A7(74) are (II, Fig. 3b) (Fragkoudis et al., 2007). Our data strongly 
support the hypothesis that induction of low-level blood viraemia is the reason 
why SFV4 is not able to invade the CNS after i.p. inoculation. It is not clear 
why SFV4 does not replicate to high titres in peripheral tissues, but it is likely 
mediated by the type-I interferon response because in IFNAR-/- mice, SFV4 and 
SFV A7(74) induce similar very high virus titres in blood (Fragkoudis et al., 
2007). 
 
 
3.2.1. Neurons and oligodendrocytes differ  
in their ability to permit replication of SFV (II) 
 
We used immunohistochemistry to determine the cell tropism of recombinant 
viruses in adult mouse brains. We observed that both SFV4(3H)-EGFP and 
SFV4-stEGFP efficiently infected neurons and oligodendrocytes in the CNS but 
never astrocytes (II, Fig. 5). This is in agreement with general cell tropism 
results published for SFV (Gates et al., 1985; Fazakerley et al., 2006). 
Histopathological analysis of brains from mice inoculated i.c. with 
SFV4(3H)-EGFP demonstrated only a few EGFP-positive cells, which were 
generally dull green and were most frequently in white matter tracts (II, Fig. 
4a,b). Immunostaining with antibodies specific to nsP3 or virus structural 
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proteins demonstrated that many neurons and oligodendrocytes were infected, 
but a strong EGFP signal could be observed only in oligodendrocytes and the 
EGFP signal was very low or undetectable in majority of infected neurons (II, 
Fig. 4c,d, Fig. 5c,d,g). As EGFP encoded by SFV4(3H)-EGFP is a good 
indicator of on-going ns protein synthesis due to its short half-life, these results 
suggest that synthesis of virus replicase proteins is rapidly downregulated in 
neurons while it remains active for longer periods in oligodendrocytes. As 
nsP3-specific immunostaining signal could be seen in many neurons and 
oligodendrocytes, we conclude that the replicase complexes were long-lived and 
present in both neurons and oligodendrocytes. 
In SFV4-stEGFP-infected brains, widespread EGFP signal was seen in the 
corpus callosum and other white matter tracts, and large EGFP-positive foci 
could be detected throughout the brain (II, Fig. 4g). In contrast to SFV4(3H)-
EGFP, EGFP signal was detected both in many neurons and oligodendrocytes 
(II, Fig. 5b,h). Immunostaining revealed that the majority of EGFP-positive 
cells were nsP3-positive, but also nsP3-positive and EGFP-negative cells could 
be found. The latter were most common around the expanding edge of foci of 
infection indicative of cells at early stages of infection (II, Fig. 4i-k). These 
results demonstrate that both neurons and oligodendrocytes switch to virus 
structural protein synthesis in adult mouse brains. 
 
 
3.3. Mature but not immature neurons rapidly 
downregulate virus protein synthesis (II, unpublished) 
 
We wanted to confirm the rapid downregulation of virus replicase synthesis 
observed in mature neurons in adult mouse brains and also analysed the 
infection in cultured neurons. To enable easy quantification of virus polyprotein 
synthesis, we constructed recombinant viruses expressing Renilla luciferase 
(Rluc) as part of virus ns or structural polyproteins, designated SFV4(3H)-Rluc 
and SFV4-stRluc, respectively. We infected immature and mature primary rat 
hippocampal neuronal cultures with SFV4(3H)-EGFP or SFV4(3H)-Rluc and 
observed the rapid suppression of replicase synthesis of both viruses in mature 
neurons but not in immature neurons (II, Fig. 6a, 7a). Interestingly, we also 
observed the rapid downregulation of virus structural protein synthesis speci-
fically in mature neurons and not in immature neurons infected with SFV4-
stRluc (II, Fig. 7b). Rapid downregulation of virus structural protein synthesis 
likely also takes place in vivo, but remained undetected due to the very long 
half-life of EGFP produced by SFV4-stEGFP. 
We also studied SFV replicase synthesis in undifferentiated and diffe-
rentiated cells from the neuronal cell line CSM14.1, which is a stable rat 
embryonic neuronal cell line immortalised with a temperature-sensitive SV40 
Large T-antigen (Durand 1990). At permissive temperature, these cells 
proliferate and maintain undifferentiated status, but undergo differentiation at 
non-permissive culture conditions, and thus represent a cell line easy to 
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maintain and differentiate. In fact, this cell line has been successfully used as a 
model system to study SINV replication in immature and mature neurons 
(Vernon 2005, Park 2009). We infected undifferentiated and differentiated 
CSM14.1 neurons with SFV4(3H)-Rluc and again saw rapid downregulation of 
virus ns-polyprotein synthesis specifically in mature cells (Figure 4). The levels 
of virus replicase proteins gradually increased until 24 h post-infection in 
undifferentiated cells, but reached a peak by 8 h post-infection in differentiated 
neurons. Taken together, with the use of two different cell lines, we 
demonstrated that only mature neurons rapidly downregulated both virus ns and 
structural protein synthesis. In immature neurons, synthesis of virus proteins 
remained high even in later stages of infection. 
 
 
 
 
Figure 4. Mature but not immature neurons downregulate virus ns polyprotein synthe-
sis. Undifferentiated and differentiated CSM14.1 neuronal cultures were infected with 
SFV4(3H)-Rluc and at selected time points, cells were lysed and Rluc activity was 
measured. The means of triplicate cultures with standard deviations are shown. 
 
 
3.4. Properties of SFV4 and SFV A7(74) infection  
in immature and mature neurons (unpublished) 
 
Age-dependent neurovirulence has been described for many alphaviruses and 
obtained data suggest that the maturity of neurons and not the immune system 
plays the major role in this phenomenon (Fazakerley et al., 1993; Oliver et al., 
1997; Griffin, 2005; Fragkoudis et al., 2007). Nevertheless, the exact mecha-
nism behind it has not been revealed. Our data obtained from adult mouse 
brains and cultured neurons was very similar and suggested that CSM14.1 cells 
might be a good model system to study SFV age-dependent neurovirulence. We 
compared the infection cycle of two SFV strains differing in their neuro-
virulence, SFV4 and SFV A7(74), in CSM14.1 cells. Both of these strains 
replicate efficiently in the CNS of neonatal mice, but only SFV4 is strongly 
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neurovirulent in adult mice and the replication of SFV A7(74) remains 
restricted specifically in neurons in the mature CNS (Fazakerley et al., 1993).  
To enable the visualisation of on-going infection, we used recombinant 
marker viruses expressing a fluorescent protein ZsGreen in fusion with nsP3, 
designated SFV4-Xho-ZsGreen, and SFVA7(74)-Xho-ZsGreen. In these 
recombinant viruses, the marker gene is also inserted into the nsP3 hyper-
variable domain as in the above-described SFV4(3F)-EGFP, but into a slightly 
different location, resulting in genetically stable viruses (A. Merits. unpublished 
data). First, we compared the growth kinetics of SFV4 and SFVA7(74)-based 
recombinant viruses in undifferentiated and differentiated CSM14.1 cells 
(Figure 5A). Both strains replicated efficiently in immature neurons, and to our 
surprise, they also replicated relatively well in differentiated cells. In the case of 
both strains, the release of infectious virions was considerably delayed in 
differentiated neurons compared to undifferentiated cells. This difference can be 
explained, at least to some extent, by limited synthesis of virus ns proteins in 
mature neurons (Figure 4). Compared to SFV4-Xho-ZsGreen, SFVA7(74)-Xho-
ZsGreen presented delayed growth in neuronal cultures and the difference was 
more pronounced in mature neurons (Figure 5). However, both strains were able 
to efficiently spread in and kill both immature and mature neuronal cultures. 
These results are different from previous mouse studies where SFV A7(74) 
replication did not spread and remained confined to small foci in adult mouse 
brains (Fazakerley et al., 1993).  
We also analysed the synthesis of virus replicase proteins in undifferentiated 
CSM14.1 cells infected by SFV4 and SFVA7(74)-based reporter viruses 
expressing Rluc (Figure 5B). The obtained data indicated that both virus strains 
efficiently synthesised the ns polyproteins, but SFV A7(74) had a slight delay 
compared to SFV4, similar to infectious virion accumulation (Figure 5). 
However, by 12 h post-infection, the SFV A7(74) expressed equal or slightly 
higher amounts of ns polyproteins compared to SFV4 (Figure 5B). The delay in 
replicase synthesis in SFV A7(74)-infected cells can contribute to the delay in 
virion formation but also additional defects in other virus life cycle steps should 
be considered and we plan to analyse them in near future. 
Taken together, compared to SFV4, SFV A7(74) had slightly delayed 
growth in immature and, especially, in mature CSM14.1 neurons. Although, the 
replication of SFV A7(74) in differentiated CSM14.1 cells was not as severely 
affected as in an adult CNS, this cell line is a valuable model for analysis of the 
aspects of SFV neuropathology that cannot be studied in animal models. Many 
studies have shown that it is rather common that small changes in virus 
replication in tissue culture conditions translate into more severe defects in 
animal models. There are several possibilities how the in vitro differentiated 
neurons could differ from mature neurons in the mouse brain, including the 
metabolic activity and cellular membrane availability for virus replication, 
antiviral gene expression, formed cellular connections between both neurons 
and neuron-glial cells aiding the antiviral response.  
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Figure 5. (A) The growth kinetics of SFV4 and SFV A7(74) in undifferentiated and 
differentiated neuronal cells. CSM14.1 cells were infected with SFV4-Xho-ZsGreen or 
SFVA774-Xho-ZsGreen at an MOI of 0.1 at 31C and at selected time points post-
infection, the amount of infectious virus released into media was measured. (B) The 
synthesis of virus ns polyproteins in undifferentiated cells. Undifferentiated CSM14.1 
cells were infected with SFV4(3H)-Rluc or SFVA774(3H)-Rluc at an MOI of 3 at 31C 
and at selected time points the Rluc activity, indicative of virus ns polyprotein synthesis, 
was measured. The means of triplicate cultures with standard deviations are shown. 
 
 
3.5. Properties of nsP1 and its interference  
with virus infection (III) 
 
Alphavirus nsP1 is an important player in virus infection. It is involved in the 
capping of virus RNAs and is the sole membrane anchor for the replication 
complexes (Kääriäinen and Ahola, 2002; Salonen et al., 2003). nsP1 is modified 
by palmitoylation but the exact biological significance of this modification is 
unknown. nsP1 expression in transfected or infected cells results in clearly 
detectable changes such as induction of filopodia-like structures and rearrange-
ments of actin filaments, suggesting that this protein might contribute to 
induction of cytotoxic effects characteristic to alphavirus-infected cells (Laak-
konen et al., 1998). 
We used tetracycline-inducible stable HEK293 T-Rex cell lines expressing 
SFV nsP1 or its palmitoylation-negative mutant form nsP16D (aa 418–420 
CCCAAA) to study the effect of nsP1 on the host cell and SFV infection 
cycle. The induced expression levels of nsP1 and nsP16D in stable cell lines 
were comparable to nsP1 levels in virus-infected cells (III, Fig. 1a). nsP1 
expressed in both stable cell lines and in SFV-infected cells was stable with an 
approximate half-life of 5 h (III, Fig. 1b). Similar to previously published data, 
both nsP1 and nsP16D expressed by stable cell lines localised to the plasma 
membrane, while only nsP1 induced a large number of filopodia-like structures 
(III, Fig. 2) (Laakkonen et al., 1998; Zusinaite et al., 2007). 
As nsP1 induces filopodia-like structures and mediates rearrangements of 
actin filaments (Laakkonen et al., 1998), we hypothesised that this ns protein 
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might contribute to the cytopathic effect seen in SFV-infected cells. Surpri-
singly, expression of nsP1 or its palmitoylation-deficient form had no detectable 
effect on any cellular process tested, including transcription, translation and cell 
viability (III, Fig. 3). These findings support the hypothesis that nsP2 alone is 
the main factor for inducing cellular transcription/translation shutdown and the 
death of infected cells (Garmashova et al., 2007; Akhrymuk et al., 2012). 
Infection by many different viruses, including alphaviruses, induces an intra-
cellular state blocking further infection by homologous virus – a phenomenon 
called superinfection exclusion or homologous interference. Several studies 
have proposed, but not directly demonstrated, that in alphavirus infection, the 
cleaved form of nsP2 is likely mediating this process (Karpf et al., 1997; 
Sawicki et al., 2006; Lulla et al., 2012). Possible participation of other ns 
proteins in alphavirus superinfection exclusion has not been properly addressed. 
We determined that the induction of nsP1 or nsP16D expression prior to 
infection did not affect the numbers of successfully infected cells (III, Fig. 4b), 
indicating that individual nsP1 does not play a role in superinfection exclusion. 
After completion of our study, a similar stable cell line approach was used to 
demonstrate involvement of nsP3 in slightly reducing the infection efficiency of 
incoming virus (Varjak et al., 2010). 
Next we studied if induction of nsP1 or nsP16D expression prior to infection 
with SFV interfered with the virus infection cycle. We demonstrated that 
expression of nsP1 and its mutant significantly inhibited the extracellular 
accumulation of virions (III, Fig. 4c). As nsP1 did not affect virus entry, the 
reduced extracellular titres could be due to the defects in synthesis of virus 
RNA or polyproteins, assembly and release of virions. To monitor the accu-
mulation of virus polyproteins, we used recombinant viruses SFV4(3H)-Rluc 
and SFV4-stRluc and produced Rluc activity was used to estimate the 
accumulation of virus polyproteins in infected cells (II, Fig. 1a). We found that 
expression of nsP1 and nsP16D significantly reduced synthesis of virus 
polyproteins. The ns polyproteins levels were approximately 2–3-fold lower in 
both nsP1- and nsP16D-expressing cells compared to non-induced cells (III, Fig. 
5). The accumulation of structural polyprotein was even more reduced in both 
nsP1- and nsP16D-expressing cells, however, the structural polyprotein levels 
were restored later in infection in nsP1-expressing cells but remained low in the 
presence of nsP16D (III, Fig. 5). To verify these findings, we also analysed 
synthesis of virus-specific RNA in nsP1-expressing and in non-induced cells 
(III, Fig. 6). The accumulation of virus RNAs correlated well with virus 
polyprotein synthesis.  
Taken together, expression of nsP1 interfered with the virus infectious cycle 
and resulted in reduced levels of virus genomic RNA and replicase proteins, 
delayed synthesis of structural proteins and reduced levels of released infectious 
virus. The expression of nsP16D had similar effects, except the synthesis of 
subgenomic RNA and accumulation of structural proteins remained low also 
later in infection.  
 40
Previously published data show that palmitoylation of nsP1 is important for 
efficient SFV replication and pathogenesis in mice. Nevertheless, the exact 
biological function of this modification remains unknown. In our experiments, 
the effects of nsP1 and its palmitoylation-deficient mutant were very similar on 
virus infection cycle. Thus, we could not reveal novel biological functions of 
nsP1 palmitoylation or the exact steps of infection cycle where this modification 
might be essential. These questions remain to be answered by further studies. 
There are several possible mechanisms that would explain how nsP1 and 
nsP16D expressed in trans could interfere with virus replication, some of which 
were not known at the time this study was performed. SFV replication takes 
place in association with modified cellular membranes and starts initially at the 
plasma membrane where the sites of replication, membrane invaginations called 
spherules, are initially formed (Frolova et al., 2010; Spuul et al., 2010). Both 
nsP1 and nsP16D expressed by stable cell lines were localised to plasma 
membrane and could affect membrane interactions of virus ns polyproteins and 
reduce efficiency of virus replication complex formation. Plasma membrane-
bound nsP1 and nsP16D could also be brought into spherules as part of the 
invaginating membrane and affect the proper functioning of replication 
complexes. Reduced numbers of functional replicase would result in decreased 
levels of virus RNA and polyproteins, as observed in our study. 
It is unlikely that nsP1 or nsP16D expressed by stable cell lines would be 
efficiently incorporated into virus RNA synthesis machinery and result in 
aberrant activity of replicase. Ns proteins expressed in a polyprotein efficiently 
form a strong complex while individually expressed ns proteins do not interact 
with each other very well, indicating that in trans expressed nsP1 cannot most 
likely efficiently interact with the active enzymatic complex (Salonen et al., 
2003). However, this does not exclude many subtle ways that nsP1 or nsP16D 
might interfere with replicase functioning. 
Expression of nsP1 and nsP16D might also reduce the availability of nsP1-
interacting host factors important for replication. Studies have shown that 
interactions between nsP1 and nsP4, which are crucial for minus-strand 
synthesis, are also host-dependent, suggesting a possible role for host factors 
mediating this interaction and virus replication (Shirako et al., 2000; Fata et al., 
2002; Rupp et al., 2011). 
Both nsP1 and nsP16D can compete with replicase complexes for the sub-
strates for cap synthesis, and this has also been suggested for truncated forms of 
SINV nsP1 (Li et al., 1997). In HeLa cells, stable expression of nsP1 did not 
have a significant effect on SINV replication while expression of the truncated 
forms of nsP1 strongly interferes with SINV multiplication (Li et al., 1997). The 
main mechanism suggested by authors was competition for substrates for cap 
synthesis reactions between cellular and viral nsP1 proteins. 
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4. SUMMARY 
 
We designed and characterised novel SFV-based reporter viruses expressing 
marker proteins easy to visualise or quantify, facilitating infection studies both 
in cell cultures and animals. Novel recombinant virus SFV4(3H)-EGFP expres-
sing EGFP as cleavable component of the virus non-structural polyprotein 
demonstrated excellent genomic stability during passaging both in cultured cells 
and in mouse brains. The growth kinetics, accumulation of viral proteins and 
RNA, and shutdown of host cell translation were slightly reduced in infected 
cell cultures, but the pathology and course of infection in adult mice was 
indistinguishable from parental SFV4. Thus, SFV4(3H)-EGFP represents an 
excellent tool for infection studies, both in cell cultures and animal models. This 
design has subsequently served as a prototype for several recombinant viruses 
successfully used by our group and others. 
The recombinant virus SFV4-stEGFP expressing EGFP as a cleavable com-
ponent of the structural polyprotein demonstrated excellent genetic stability 
after passages in adult mouse brain, but showed delayed growth and increased 
instability upon passage in BHK-21 cells. SFV4-stEGFP was also slightly atte-
nuated in adult mice. Nevertheless, it remained neurovirulent, efficiently repli-
cated in the CNS, and produced high levels of EGFP easy to visualise, and thus 
represents an excellent tool for monitoring infection. 
While EGFP is in general a stable protein, we determined that the half-life of 
SFV4(3H)-EGFP-encoded marker protein was less than 2 h, indicative of the 
presence of highly destabilising sequences. We hypothesised that the additional 
amino acids in its carboxy terminus, originating from the duplication of the C-
terminus of nsP3, must contain an efficient degradation signal. This assumption 
was later experimentally confirmed (Varjak et al., 2010). 
Experiments described in this thesis reveal novel properties of the adult 
mouse CNS in response to SFV infection. We demonstrated that the synthesis 
of virus replicase proteins is rapidly downregulated in neurons, but it remains 
active for longer periods in oligodendrocytes in adult mouse brains. Neverthe-
less, the replication complexes themselves were long-lived and were present in 
both neurons and oligodendrocytes. We also observed that both neurons and 
oligodendrocytes switch from replicase to structural protein synthesis. We also 
demonstrated that the response to infection depends on the differentiation state 
of neurons. Only mature neurons rapidly downregulated both virus non-struc-
tural and structural protein synthesis. In immature neurons, synthesis of virus 
proteins remained high even in later stages of infection. 
We used a combination of inducible stable cell lines expressing SFV nsP1 or 
its palmitoylation-negative mutant nsP16D and constructed reporter viruses to 
study the effect of nsP1 on the host cell and also on SFV infection cycle. We 
demonstrated that expression of nsP1 or its palmitoylation-deficient form had 
no detectable effect on any cellular processes tested, including transcription, 
translation or cell viability, indicating that nsP1 does not play a direct role in the 
induction of CPE, a hallmark of alphavirus infection. We also demonstrated that 
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nsP1 does not play a role in superinfection exclusion. In trans expression of 
nsP1 or its palmitoylation-deficient mutant interfered with virus infectious cycle 
and reduced the accumulation of virus RNA, non-structural and structural 
polyproteins, and ultimately release of infectious virions. 
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SUMMARY IN ESTONIAN 
 
Semliki Forest viiruse replikatsiooni ja  
patogeensuse uurimine 
 
Alfaviirused on laialt levinud selgroogsete patogeenid, mis põhjustavad erine-
vate sümptomitega haigusi, sealhulgas artriiti ja entsefaliiti. Alfaviiruste genoo-
miks on üheahelaline positiivse polaarsusega RNA molekul, mille üks avatud 
lugemisraam kodeerib mittestruktuurseid, replikatsioonikompleksi moodusta-
vaid valke ja teine struktuurseid, virioni moodustamiseks vajalikke valke. Alfa-
viiruste genoomi replikatsiooni toimumist ja erinevate viirusvalkude osalust 
selles protsessis on detailselt kirjeldanud paljud uuringud, kuid viirus-peremees 
suheteid ja patogeensust mõjutavad protsesse ei mõisteta veel nii hästi. Neid 
protsesse on sageli raske adekvaatselt koekultuuri tingimutes modelleerida, 
samuti on infektsiooni jälgmine elusorganismis väga keeruline, sest viirus-
nakkus on kompleksne ja hõlmab erinevaid kudesid ning rakutüüpe. 
Üheks kõige põhjalikumalt uuritud alfaviiruseks on Semliki Forest viirus 
(SFV). SFV-alased uuringud on andnud väärtuslikke teadmisi ka teiste alfa-
viiruste infektsioonitsüklite ja erinevate nakkusega seotud rakuliste protsesside 
kohta. Käesoleva uurimistöö peaeesmärgiks oli välja töötada uudsed SFV 
nakkuse uurimist hõlbustavaid markervalke ekspresseerivad rekombinantsed 
viirused ja kasutada neid viirusnakkuse protsessi ja dünaamika analüüsimiseks 
nii koekultuuri tingimustes kui ka hiirtes. Konstrueeritud rekombinantsed 
viirused ekspresseerisid markervalke osana kas viiruse mittestruktuursest või 
struktuursest polüproteiinist. Rekombinantne viirus, mis sisaldas roheliselt 
fluorestseeruvat valku (EGFP) osana viiruse mittestruktuursest polüproteiinist, 
säilitas margergeeni oma genoomis nii koekultuuri tingimustes kui ka täis-
kasvanud hiire ajus mitme järjestikuse viiruspõlvkonna jooksul. Nii täiskasva-
nud hiires toimuvale infektsioonile kui ka patogeensusele ei omanud lisatud 
marker mingit mõju, hoolimata sellest, et koekultuuri rakkudes oli konstruee-
ritud viiruse replikatsioon mõnevõrra aeglasem kui ilma võõrgeenita viirusel. 
Ka need rekombinantsed viirused, kus EGFP oli sisestatud viiruse struktuur-
sesse polüproteiini, olid täiskasvanud hiire ajus paljunedes geneetiliselt stabiil-
sed. Koekultuuri tingimustes oli antud viiruse paljunemine aga aeglustunud ja 
viirusgenoom ebastabiilsem, ka viiruse paljunemine täiskasvanud hiirtes oli 
märgatavalt ebaefektiivsem kui markergeenita viirusel. Samas ei olnud sellise 
rekombinantse viiruse patogeensus markergeeni lisamise tõttu täiskasvanud 
hiirtes muutunud. Kokkuvõtlikult võib öelda, et vaatamata täheldatud effekti-
dele viiruse replikatsioonile, ei muutnud markeri lisamine viiruse genoomi 
mittestruktuursesse või struktuursesse alasse viirusnakkuse üldist kulgu ega ise-
loomu täiskasvanud hiirtes. Seega sobivad meie poolt disainitud rekombi-
nantsed viirused SFV infektsiooni uurimiseks hiirtes. 
Jälgides rekombinantsete viiruste nakkust täiskasvanud hiire kesknärvisüs-
teemis leidsime, et erinevat tüüpi rakkudes oli SFV replikatsioon erineva 
dünaamikaga. Neuronites suruti SFV replikaasivalkude süntees kiiresti maha, 
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kuid oligodendrotsüütides toodeti viiruse mittestruktuurseid valke ka infekt-
siooni lõppstaadiumis. Samas olid juba formeerunud replikatsioonikompleksid 
mõlemat tüüpi rakkudes stabiilsed ning detekteeritavad ka hilistes infektsiooni-
staadiumites. Lisaks leidsime, et neuronite vastus SFV infektsioonile sõltub 
antud rakutüübi diferentseerituse astmest – efektiivne viirusvalkude sünteesi 
mahasurumine toimus ainult diferentseeritud neuronites ja noortes diferentsee-
rumata neuronites sünteesiti viirusvalke kõrgel tasemel ka hilistes infektsiooni-
etappides. Sellest tulenevalt oli SFV paljunemine noortes neuronites palju 
efektiivsem ja infektsiooniliste virionide vabanemine toimus antud rakkudes 
tunduvalt varem kui diferentseeritud neuronites. 
Käesolev uurimistöö keskendus ka mittestruktuurse viirusvalgu nsP1 oma-
duste kirjeldamisele. Katsed rekombinantsete viiruste ja nsP1 valku indutseeri-
tavalt ekspresseerivate rakuliinidega näitasid, et nsP1 ei mõjuta rakkude elu-
lemust või metabolismi ning seega tõenäoliselt ei osale antud valk alfaviirustele 
omase tsütopaatilise efekti tekitamises. Eelnev nsP1 ekspressioon ei mõjutanud 
ka viiruse sisenemist rakkudesse, mistõttu võib oletada, et nsP1 ei osale SFV 
superinfektsiooni peatamises. Samas mõjutas in trans ekspresseeritud nsP1 SFV 
nakkuse kulgu, vähendades viiruse RNA ning valkude taset rakus ning seeläbi 
ka vabanenud infektsiooniliste virionide hulka. 
Saadud tulemused aitavad paremini mõista nii SFV kui teiste alfaviiruste 
infektsiooni ja patogeneesi selgroogsete, kaasa arvatud inimese, organismis. 
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